| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.606 | 0.004 | 0.606 | Alkylator | 0.372 0.009 DBMET03682 0.419 0.007 DBMET03683 0.334 0.011 DBMET03684 0.357 0.009 DBMET03686 0.353 0.01 DBMET03688 0.366 0.009 DBMET03690 0.335 0.011 DBMET03685 0.147 0.048 DBMET03687 0.17 0.037 DBMET03689 | ||
| 0.556 | 0.059 | 0.827 | Apoptosis agonist | 0.827 0.013 DBMET03682 0.307 0.167 DBMET03683 0.818 0.015 DBMET03684 0.437 0.097 DBMET03686 0.422 0.103 DBMET03688 0.39 0.119 DBMET03690 0.81 0.015 DBMET03687 0.787 0.018 DBMET03689 | DBMET03682 | |
| 0.37 | 0.02 | 0.488 | 5 Hydroxytryptamine uptake stimulant | 0.433 0.009 DBMET03682 0.374 0.02 DBMET03683 0.488 0.005 DBMET03684 0.488 0.005 DBMET03686 0.465 0.006 DBMET03688 0.216 0.123 DBMET03690 0.488 0.005 DBMET03685 0.461 0.006 DBMET03687 0.432 0.009 DBMET03689 | DBMET03685 | |
| 0.327 | 0.003 | 0.513 | Thioredoxin inhibitor | 0.504 0.001 DBMET03682 0.447 0.001 DBMET03683 0.513 0.001 DBMET03684 0.299 0.003 DBMET03686 0.298 0.003 DBMET03688 0.249 0.005 DBMET03690 0.227 0.006 DBMET03685 0.282 0.004 DBMET03687 0.27 0.004 DBMET03689 | DBMET03684 | |
| 0.315 | 0.015 | 0.67 | Alpha-N-acetylglucosaminidase inhibitor | 0.67 0.003 DBMET03682 0.348 0.012 DBMET03683 0.564 0.004 DBMET03684 0.46 0.006 DBMET03686 0.371 0.01 DBMET03688 0.173 0.044 DBMET03690 0.564 0.004 DBMET03685 0.663 0.003 DBMET03687 0.616 0.004 DBMET03689 | DBMET03682 | |
| 0.274 | 0.049 | 0.437 | Tyrosine 3 hydroxylase inhibitor | 0.378 0.011 DBMET03682 0.271 0.051 DBMET03683 0.361 0.014 DBMET03684 0.437 0.005 DBMET03686 0.42 0.006 DBMET03688 0.269 0.052 DBMET03690 0.361 0.014 DBMET03685 0.331 0.021 DBMET03687 0.309 0.029 DBMET03689 | DBMET03686 | |
| 0.216 | 0.018 | 0.54 | GABA C receptor agonist | 0.54 0.003 DBMET03682 0.241 0.014 DBMET03683 0.433 0.004 DBMET03684 0.439 0.004 DBMET03686 0.407 0.005 DBMET03688 0.124 0.047 DBMET03690 0.433 0.004 DBMET03685 0.515 0.004 DBMET03687 0.471 0.004 DBMET03689 | DBMET03682 | |
| 0.253 | 0.064 | 0.44 | DNA synthesis inhibitor | 0.376 0.025 DBMET03682 0.376 0.025 DBMET03683 0.386 0.024 DBMET03684 0.431 0.018 DBMET03686 0.44 0.018 DBMET03688 0.328 0.035 DBMET03690 0.386 0.024 DBMET03685 0.375 0.025 DBMET03687 0.35 0.03 DBMET03689 | DBMET03688 | |
| 0.155 | 0.032 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.17 0.013 DBMET03682 0.155 0.032 DBMET03683 0.176 0.009 DBMET03684 0.145 0.056 DBMET03686 0.143 0.063 DBMET03688 0.176 0.009 DBMET03685 0.18 0.007 DBMET03687 0.175 0.01 DBMET03689 | DBMET03687 | |
| 0.3 | 0.193 | 0.422 | Caspase 9 stimulant | 0.422 0.099 DBMET03682 0.415 0.102 DBMET03684 0.415 0.102 DBMET03685 0.331 0.162 DBMET03687 0.293 0.202 DBMET03689 | DBMET03682 | |
| 0.104 | 0.044 | 0.297 | Triose-phosphate isomerase inhibitor | 0.252 0.007 DBMET03682 0.115 0.035 DBMET03683 0.196 0.011 DBMET03684 0.153 0.019 DBMET03686 0.138 0.024 DBMET03688 0.196 0.011 DBMET03685 0.297 0.005 DBMET03687 0.262 0.006 DBMET03689 | DBMET03687 | |
| 0.155 | 0.104 | 0.291 | Succinate dehydrogenase inhibitor | 0.269 0.017 DBMET03682 0.164 0.089 DBMET03683 0.227 0.032 DBMET03684 0.248 0.023 DBMET03686 0.241 0.026 DBMET03688 0.227 0.032 DBMET03685 0.291 0.012 DBMET03687 0.271 0.016 DBMET03689 | DBMET03687 | |
| 0.078 | 0.03 | 0.405 | Carbamoyl phosphate synthetase inhibitor | 0.184 0.008 DBMET03682 0.088 0.025 DBMET03683 0.147 0.012 DBMET03684 0.335 0.004 DBMET03686 0.405 0.003 DBMET03688 0.134 0.013 DBMET03690 0.147 0.012 DBMET03685 0.139 0.013 DBMET03687 0.125 0.015 DBMET03689 | DBMET03688 | |
| 0.224 | 0.179 | 0.426 | GABA C receptor rho-3 antagonist | 0.286 0.125 DBMET03682 0.284 0.127 DBMET03683 0.426 0.05 DBMET03684 0.426 0.05 DBMET03685 0.285 0.126 DBMET03687 0.25 0.154 DBMET03689 | DBMET03685 | |
| 0.084 | 0.039 | 0.218 | Phosphofructokinase-1 inhibitor | 0.174 0.014 DBMET03682 0.073 0.045 DBMET03683 0.138 0.02 DBMET03684 0.192 0.012 DBMET03686 0.218 0.009 DBMET03688 0.078 0.042 DBMET03690 0.138 0.02 DBMET03685 0.167 0.015 DBMET03687 0.151 0.018 DBMET03689 | DBMET03688 | |
| 0.109 | 0.065 | 0.198 | GABA C receptor antagonist | 0.162 0.024 DBMET03682 0.116 0.056 DBMET03683 0.198 0.013 DBMET03684 0.144 0.034 DBMET03686 0.132 0.042 DBMET03688 0.198 0.013 DBMET03685 0.172 0.02 DBMET03687 0.153 0.028 DBMET03689 | DBMET03685 | |
| 0.178 | 0.136 | 0.262 | RNA-directed DNA polymerase inhibitor | 0.234 0.061 DBMET03682 0.241 0.055 DBMET03684 0.241 0.055 DBMET03685 0.262 0.043 DBMET03687 0.24 0.056 DBMET03689 | DBMET03687 | |
| 0.08 | 0.038 | 0.184 | Glycine receptor agonist | 0.128 0.01 DBMET03682 0.078 0.042 DBMET03683 0.126 0.011 DBMET03684 0.184 0.005 DBMET03686 0.163 0.005 DBMET03688 0.126 0.011 DBMET03685 0.146 0.007 DBMET03687 0.129 0.01 DBMET03689 | DBMET03686 | |
| 0.099 | 0.062 | 0.241 | UDP-glucose 4-epimerase inhibitor | 0.155 0.027 DBMET03682 0.119 0.044 DBMET03683 0.203 0.018 DBMET03684 0.097 0.064 DBMET03686 0.203 0.018 DBMET03685 0.241 0.014 DBMET03687 0.21 0.017 DBMET03689 | DBMET03687 | |
| 0.097 | 0.062 | 0.23 | Creatine kinase inhibitor | 0.191 0.012 DBMET03682 0.126 0.037 DBMET03683 0.206 0.01 DBMET03684 0.192 0.012 DBMET03686 0.174 0.016 DBMET03688 0.206 0.01 DBMET03685 0.23 0.007 DBMET03687 0.208 0.009 DBMET03689 | DBMET03687 | |
| 0.099 | 0.064 | 0.174 | GABA C receptor rho-1 antagonist | 0.147 0.023 DBMET03682 0.105 0.056 DBMET03683 0.174 0.013 DBMET03684 0.105 0.055 DBMET03686 0.094 0.071 DBMET03688 0.174 0.013 DBMET03685 0.152 0.02 DBMET03687 0.136 0.028 DBMET03689 | DBMET03685 | |
| 0.056 | 0.022 | 0.088 | Glucose-6-phosphate isomerase inhibitor | 0.088 0.007 DBMET03682 0.053 0.025 DBMET03683 0.076 0.01 DBMET03684 0.057 0.021 DBMET03686 0.054 0.024 DBMET03688 0.076 0.01 DBMET03685 0.071 0.012 DBMET03687 0.066 0.014 DBMET03689 | DBMET03682 | |
| 0.175 | 0.148 | 0.685 | Superoxide dismutase inhibitor | 0.362 0.034 DBMET03682 0.216 0.101 DBMET03683 0.382 0.03 DBMET03684 0.524 0.011 DBMET03686 0.685 0.004 DBMET03688 0.476 0.015 DBMET03690 0.382 0.03 DBMET03685 0.411 0.025 DBMET03687 0.36 0.034 DBMET03689 | DBMET03688 | |
| 0.086 | 0.06 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.039 DBMET03682 0.083 0.066 DBMET03683 0.112 0.022 DBMET03684 0.079 0.077 DBMET03686 0.112 0.022 DBMET03685 0.097 0.039 DBMET03687 0.09 0.051 DBMET03689 | DBMET03685 | |
| 0.134 | 0.108 | 0.198 | Arachidonic acid antagonist | 0.198 0.034 DBMET03682 0.146 0.093 DBMET03683 0.195 0.038 DBMET03684 0.157 0.08 DBMET03686 0.146 0.093 DBMET03688 0.195 0.038 DBMET03685 0.193 0.04 DBMET03687 0.184 0.049 DBMET03689 | DBMET03682 | |
| 0.06 | 0.036 | 0.292 | Argininosuccinate synthase inhibitor | 0.186 0.009 DBMET03682 0.069 0.031 DBMET03683 0.141 0.012 DBMET03684 0.262 0.005 DBMET03686 0.292 0.004 DBMET03688 0.1 0.019 DBMET03690 0.141 0.012 DBMET03685 0.166 0.01 DBMET03687 0.145 0.012 DBMET03689 | DBMET03688 | |
| 0.25 | 0.228 | 0.551 | 5 Hydroxytryptamine release inhibitor | 0.351 0.114 DBMET03682 0.376 0.094 DBMET03684 0.306 0.159 DBMET03686 0.278 0.191 DBMET03688 0.376 0.094 DBMET03685 0.551 0.019 DBMET03687 0.517 0.027 DBMET03689 | DBMET03687 | |
| 0.093 | 0.073 | 0.132 | Anabolic | 0.122 0.037 DBMET03682 0.097 0.067 DBMET03683 0.132 0.029 DBMET03684 0.109 0.051 DBMET03686 0.116 0.044 DBMET03688 0.115 0.044 DBMET03690 0.132 0.029 DBMET03685 0.129 0.032 DBMET03687 0.121 0.039 DBMET03689 | DBMET03685 | |
| 0.097 | 0.079 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.097 0.08 DBMET03682 0.158 0.031 DBMET03683 0.228 0.008 DBMET03684 0.228 0.008 DBMET03685 0.097 0.08 DBMET03687 | DBMET03685 | |
| 0.166 | 0.149 | 0.231 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 DBMET03683 0.231 0.027 DBMET03684 0.231 0.027 DBMET03685 0.177 0.113 DBMET03687 0.168 0.141 DBMET03689 | DBMET03685 | |
| 0.094 | 0.078 | 0.274 | Ferrochelatase inhibitor | 0.274 0.01 DBMET03682 0.11 0.061 DBMET03683 0.225 0.017 DBMET03684 0.182 0.027 DBMET03686 0.163 0.033 DBMET03688 0.225 0.017 DBMET03685 0.259 0.012 DBMET03687 0.228 0.017 DBMET03689 | DBMET03682 | |
| 0.041 | 0.026 | 0.105 | Dopamine D5 agonist | 0.061 0.011 DBMET03682 0.06 0.012 DBMET03683 0.105 0.004 DBMET03684 0.042 0.026 DBMET03686 0.038 0.031 DBMET03688 0.105 0.004 DBMET03685 0.052 0.016 DBMET03687 0.046 0.021 DBMET03689 | DBMET03685 | |
| 0.069 | 0.056 | 0.642 | Glutamate decarboxylase inhibitor | 0.172 0.01 DBMET03682 0.075 0.049 DBMET03683 0.129 0.018 DBMET03684 0.515 0.002 DBMET03686 0.477 0.003 DBMET03688 0.642 0.002 DBMET03690 0.129 0.018 DBMET03685 0.197 0.007 DBMET03687 0.177 0.009 DBMET03689 | DBMET03690 | |
| 0.085 | 0.073 | 0.186 | Prolactin inhibitor | 0.156 0.02 DBMET03682 0.115 0.042 DBMET03683 0.186 0.011 DBMET03684 0.166 0.016 DBMET03686 0.157 0.02 DBMET03688 0.186 0.011 DBMET03685 0.162 0.018 DBMET03687 0.145 0.024 DBMET03689 | DBMET03685 | |
| 0.052 | 0.04 | 0.115 | Alpha-mannosidase inhibitor | 0.082 0.01 DBMET03682 0.057 0.032 DBMET03683 0.084 0.01 DBMET03684 0.115 0.005 DBMET03686 0.085 0.009 DBMET03688 0.049 0.046 DBMET03690 0.084 0.01 DBMET03685 0.103 0.006 DBMET03687 0.093 0.008 DBMET03689 | DBMET03686 | |
| 0.164 | 0.154 | 0.409 | Interleukin agonist | 0.298 0.049 DBMET03682 0.181 0.139 DBMET03683 0.302 0.047 DBMET03684 0.345 0.03 DBMET03686 0.375 0.023 DBMET03688 0.399 0.019 DBMET03690 0.302 0.047 DBMET03685 0.409 0.017 DBMET03687 0.376 0.023 DBMET03689 | DBMET03687 | |
| 0.084 | 0.074 | 0.34 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.194 0.017 DBMET03682 0.084 0.074 DBMET03683 0.158 0.024 DBMET03684 0.274 0.008 DBMET03686 0.295 0.006 DBMET03688 0.198 0.016 DBMET03690 0.158 0.024 DBMET03685 0.34 0.005 DBMET03687 0.305 0.006 DBMET03689 | DBMET03687 | |
| 0.199 | 0.192 | 0.497 | Interleukin 2 agonist | 0.372 0.037 DBMET03682 0.323 0.059 DBMET03684 0.452 0.015 DBMET03686 0.438 0.018 DBMET03688 0.416 0.023 DBMET03690 0.323 0.059 DBMET03685 0.497 0.008 DBMET03687 0.478 0.011 DBMET03689 | DBMET03687 | |
| 0.039 | 0.033 | 0.12 | Kainate receptor agonist | 0.073 0.004 DBMET03682 0.043 0.025 DBMET03683 0.061 0.006 DBMET03684 0.102 0.003 DBMET03686 0.12 0.002 DBMET03688 0.043 0.025 DBMET03690 0.061 0.006 DBMET03685 0.09 0.003 DBMET03687 0.082 0.004 DBMET03689 | DBMET03688 | |
| 0.083 | 0.078 | 0.453 | Aminopeptidase B inhibitor | 0.174 0.028 DBMET03682 0.084 0.078 DBMET03683 0.151 0.037 DBMET03684 0.297 0.009 DBMET03686 0.324 0.007 DBMET03688 0.453 0.004 DBMET03690 0.151 0.037 DBMET03685 0.221 0.017 DBMET03687 0.208 0.02 DBMET03689 | DBMET03690 | |
| 0.067 | 0.062 | 0.421 | Glutamate dehydrogenase inhibitor | 0.163 0.014 DBMET03682 0.072 0.053 DBMET03683 0.123 0.022 DBMET03684 0.346 0.005 DBMET03686 0.421 0.004 DBMET03688 0.296 0.006 DBMET03690 0.123 0.022 DBMET03685 0.18 0.012 DBMET03687 0.16 0.014 DBMET03689 | DBMET03688 | |
| 0.048 | 0.043 | 0.126 | Aconitate hydratase inhibitor | 0.119 0.006 DBMET03682 0.051 0.038 DBMET03683 0.085 0.012 DBMET03684 0.081 0.013 DBMET03686 0.077 0.015 DBMET03688 0.085 0.012 DBMET03685 0.126 0.005 DBMET03687 0.111 0.007 DBMET03689 | DBMET03687 | |
| 0.063 | 0.058 | 0.165 | Glutamate (mGluR6) antagonist | 0.107 0.008 DBMET03682 0.067 0.046 DBMET03683 0.093 0.014 DBMET03684 0.147 0.004 DBMET03686 0.165 0.003 DBMET03688 0.068 0.044 DBMET03690 0.093 0.014 DBMET03685 0.162 0.003 DBMET03687 0.146 0.004 DBMET03689 | DBMET03688 | |
| 0.103 | 0.099 | 0.168 | Cyclooxygenase 3 inhibitor | 0.162 0.039 DBMET03682 0.135 0.062 DBMET03684 0.129 0.068 DBMET03686 0.168 0.035 DBMET03688 0.109 0.091 DBMET03690 0.103 0.098 DBMET03685 0.144 0.053 DBMET03687 0.128 0.069 DBMET03689 | DBMET03688 | |
| 0.207 | 0.203 | 0.348 | Calcium channel activator | 0.277 0.116 DBMET03682 0.223 0.181 DBMET03683 0.336 0.06 DBMET03684 0.336 0.06 DBMET03685 0.348 0.051 DBMET03687 0.322 0.071 DBMET03689 | DBMET03687 | |
| 0.125 | 0.122 | 0.258 | Interferon gamma antagonist | 0.168 0.059 DBMET03682 0.125 0.121 DBMET03683 0.175 0.053 DBMET03684 0.151 0.077 DBMET03686 0.162 0.065 DBMET03688 0.175 0.053 DBMET03685 0.258 0.027 DBMET03687 0.23 0.032 DBMET03689 | DBMET03687 | |
| 0.079 | 0.077 | 0.149 | NADH dehydrogenase inhibitor | 0.142 0.02 DBMET03682 0.092 0.054 DBMET03683 0.139 0.02 DBMET03684 0.1 0.044 DBMET03686 0.087 0.062 DBMET03688 0.139 0.02 DBMET03685 0.149 0.018 DBMET03687 0.135 0.022 DBMET03689 | DBMET03687 | |
| 0.035 | 0.033 | 0.123 | Glutamate (mGluR8) agonist | 0.067 0.005 DBMET03682 0.038 0.026 DBMET03683 0.056 0.009 DBMET03684 0.107 0.003 DBMET03686 0.123 0.002 DBMET03688 0.043 0.018 DBMET03690 0.056 0.009 DBMET03685 0.081 0.004 DBMET03687 0.074 0.004 DBMET03689 | DBMET03688 | |
| 0.089 | 0.089 | 0.279 | Adenylate kinase inhibitor | 0.174 0.019 DBMET03682 0.098 0.07 DBMET03683 0.15 0.026 DBMET03684 0.257 0.009 DBMET03686 0.279 0.008 DBMET03688 0.182 0.018 DBMET03690 0.15 0.026 DBMET03685 0.19 0.016 DBMET03687 0.17 0.02 DBMET03689 | DBMET03688 | |
| 0.076 | 0.081 | 0.122 | mTOR complex 2 inhibitor | 0.08 0.069 DBMET03682 0.085 0.056 DBMET03683 0.12 0.017 DBMET03684 0.12 0.017 DBMET03685 0.122 0.016 DBMET03687 0.112 0.022 DBMET03689 | DBMET03687 | |
| 0.262 | 0.268 | 0.416 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.29 0.226 DBMET03682 0.32 0.187 DBMET03683 0.416 0.087 DBMET03684 0.416 0.087 DBMET03685 0.361 0.138 DBMET03687 0.334 0.17 DBMET03689 | DBMET03685 | |
| 0.061 | 0.067 | 0.244 | Aminopeptidase I inhibitor | 0.125 0.018 DBMET03682 0.069 0.055 DBMET03683 0.106 0.025 DBMET03684 0.196 0.007 DBMET03686 0.188 0.008 DBMET03688 0.244 0.004 DBMET03690 0.106 0.025 DBMET03685 0.155 0.012 DBMET03687 0.143 0.014 DBMET03689 | DBMET03690 | |
| 0.119 | 0.129 | 0.172 | GABA C receptor rho-2 antagonist | 0.132 0.102 DBMET03682 0.172 0.049 DBMET03684 0.172 0.049 DBMET03685 0.139 0.09 DBMET03687 0.126 0.114 DBMET03689 | DBMET03685 | |
| 0.089 | 0.1 | 0.174 | DOPA decarboxylase inhibitor | 0.15 0.021 DBMET03682 0.1 0.075 DBMET03683 0.142 0.026 DBMET03684 0.174 0.012 DBMET03686 0.162 0.016 DBMET03688 0.142 0.026 DBMET03685 0.151 0.021 DBMET03687 0.14 0.027 DBMET03689 | DBMET03686 | |
| 0.036 | 0.048 | 0.104 | Mannosidase inhibitor | 0.068 0.013 DBMET03682 0.041 0.038 DBMET03683 0.07 0.012 DBMET03684 0.104 0.005 DBMET03686 0.072 0.011 DBMET03688 0.07 0.012 DBMET03685 0.097 0.006 DBMET03687 0.085 0.008 DBMET03689 | DBMET03686 | |
| 0.162 | 0.175 | 0.232 | Nitric-oxide synthase stimulant | 0.189 0.109 DBMET03682 0.175 0.141 DBMET03683 0.23 0.049 DBMET03684 0.179 0.13 DBMET03686 0.23 0.049 DBMET03685 0.232 0.047 DBMET03687 0.218 0.063 DBMET03689 | DBMET03687 | |
| 0.011 | 0.025 | 0.025 | Thromboxane A2 agonist | 0.025 0.004 DBMET03682 0.022 0.005 DBMET03684 0.022 0.005 DBMET03685 0.017 0.009 DBMET03687 0.015 0.012 DBMET03689 | DBMET03682 | |
| 0.012 | 0.027 | 0.02 | Telomerase stimulant | 0.018 0.01 DBMET03682 0.02 0.007 DBMET03684 0.019 0.009 DBMET03686 0.017 0.013 DBMET03688 0.02 0.007 DBMET03685 0.017 0.012 DBMET03687 0.016 0.015 DBMET03689 | DBMET03685 | |
| 0.042 | 0.057 | 0.187 | Alcohol oxidase inhibitor | 0.187 0.007 DBMET03682 0.05 0.045 DBMET03683 0.13 0.013 DBMET03684 0.108 0.016 DBMET03686 0.083 0.023 DBMET03688 0.13 0.013 DBMET03685 0.178 0.008 DBMET03687 0.145 0.011 DBMET03689 | DBMET03682 | |
| 0.041 | 0.056 | 0.131 | Acyl-CoA dehydrogenase inhibitor | 0.097 0.017 DBMET03682 0.05 0.043 DBMET03683 0.093 0.018 DBMET03684 0.1 0.016 DBMET03686 0.09 0.019 DBMET03688 0.054 0.038 DBMET03690 0.093 0.018 DBMET03685 0.131 0.011 DBMET03687 0.115 0.013 DBMET03689 | DBMET03687 | |
| 0.031 | 0.047 | 0.105 | Membrane dipeptidase inhibitor | 0.062 0.009 DBMET03682 0.052 0.014 DBMET03684 0.105 0.003 DBMET03686 0.084 0.005 DBMET03688 0.094 0.004 DBMET03690 0.052 0.014 DBMET03685 0.071 0.007 DBMET03687 0.064 0.009 DBMET03689 | DBMET03686 | |
| 0.117 | 0.133 | 0.18 | Adenylate cyclase stimulant | 0.171 0.034 DBMET03682 0.136 0.089 DBMET03683 0.177 0.028 DBMET03684 0.173 0.032 DBMET03686 0.18 0.026 DBMET03688 0.141 0.078 DBMET03690 0.177 0.028 DBMET03685 0.155 0.055 DBMET03687 0.146 0.07 DBMET03689 | DBMET03688 | |
| 0.015 | 0.033 | 0.215 | Glutamate (mGluR1a) agonist | 0.051 0.005 DBMET03682 0.02 0.019 DBMET03683 0.05 0.005 DBMET03684 0.197 0.002 DBMET03686 0.215 0.002 DBMET03688 0.03 0.009 DBMET03690 0.05 0.005 DBMET03685 0.098 0.004 DBMET03687 0.07 0.004 DBMET03689 | DBMET03688 | |
| 0.006 | 0.025 | 0.072 | Glutamate (mGluR6) agonist | 0.019 0.004 DBMET03682 0.014 0.007 DBMET03684 0.072 0.002 DBMET03686 0.062 0.002 DBMET03688 0.014 0.007 DBMET03685 0.025 0.004 DBMET03687 0.021 0.004 DBMET03689 | DBMET03686 | |
| 0.021 | 0.041 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.034 0.016 DBMET03683 0.049 0.006 DBMET03684 0.049 0.006 DBMET03685 | DBMET03685 | |
| 0.036 | 0.057 | 0.368 | Ornithine carbamoyltransferase inhibitor | 0.097 0.017 DBMET03682 0.075 0.023 DBMET03684 0.303 0.004 DBMET03686 0.368 0.004 DBMET03688 0.229 0.006 DBMET03690 0.075 0.023 DBMET03685 0.101 0.016 DBMET03687 0.089 0.019 DBMET03689 | DBMET03688 | |
| 0.031 | 0.053 | 0.075 | Guanylate cyclase inhibitor | 0.06 0.012 DBMET03682 0.04 0.033 DBMET03683 0.065 0.007 DBMET03684 0.065 0.007 DBMET03685 0.075 0.004 DBMET03687 0.072 0.004 DBMET03689 | DBMET03687 | |
| 0.022 | 0.045 | 0.079 | Fumarate hydratase inhibitor | 0.066 0.009 DBMET03682 0.045 0.016 DBMET03684 0.079 0.007 DBMET03686 0.073 0.008 DBMET03688 0.045 0.016 DBMET03685 0.058 0.011 DBMET03687 0.051 0.013 DBMET03689 | DBMET03686 | |
| 0.009 | 0.033 | 0.02 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET03682 0.018 0.01 DBMET03684 0.018 0.01 DBMET03686 0.017 0.011 DBMET03688 0.018 0.01 DBMET03685 0.02 0.008 DBMET03687 0.017 0.011 DBMET03689 | DBMET03687 | |
| 0.009 | 0.033 | 0.02 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET03682 0.018 0.01 DBMET03684 0.018 0.01 DBMET03686 0.017 0.011 DBMET03688 0.018 0.01 DBMET03685 0.02 0.008 DBMET03687 0.017 0.011 DBMET03689 | DBMET03687 | |
| 0.054 | 0.078 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 DBMET03682 0.094 0.037 DBMET03684 0.094 0.037 DBMET03685 0.087 0.043 DBMET03687 0.08 0.051 DBMET03689 | DBMET03685 | |
| 0.009 | 0.036 | 0.016 | Cyclin D2 inhibitor | 0.016 0.005 DBMET03684 0.016 0.005 DBMET03685 | DBMET03685 | |
| 0.053 | 0.079 | 0.208 | Porphobilinogen synthase inhibitor | 0.208 0.011 DBMET03682 0.154 0.019 DBMET03684 0.119 0.029 DBMET03686 0.1 0.036 DBMET03688 0.154 0.019 DBMET03685 0.205 0.012 DBMET03687 0.175 0.016 DBMET03689 | DBMET03682 | |
| 0.019 | 0.046 | 0.136 | Arginase inhibitor | 0.06 0.01 DBMET03682 0.05 0.015 DBMET03684 0.118 0.003 DBMET03686 0.136 0.003 DBMET03688 0.119 0.003 DBMET03690 0.05 0.015 DBMET03685 0.089 0.005 DBMET03687 0.081 0.005 DBMET03689 | DBMET03688 | |
| 0.042 | 0.069 | 0.128 | Biliverdin reductase inhibitor | 0.123 0.013 DBMET03682 0.095 0.02 DBMET03684 0.08 0.026 DBMET03686 0.068 0.034 DBMET03688 0.095 0.02 DBMET03685 0.128 0.012 DBMET03687 0.111 0.015 DBMET03689 | DBMET03687 | |
| 0.063 | 0.091 | 0.102 | Glycine receptor antagonist | 0.08 0.056 DBMET03682 0.102 0.03 DBMET03684 0.102 0.03 DBMET03685 0.089 0.043 DBMET03687 0.079 0.058 DBMET03689 | DBMET03685 | |
| 0.042 | 0.071 | 0.081 | Nicotinic alpha3beta2 receptor antagonist | 0.081 0.013 DBMET03684 0.081 0.013 DBMET03685 0.063 0.023 DBMET03687 0.056 0.033 DBMET03689 | DBMET03685 | |
| 0.151 | 0.181 | 0.477 | 5 Hydroxytryptamine release stimulant | 0.233 0.098 DBMET03682 0.238 0.095 DBMET03683 0.477 0.031 DBMET03684 0.252 0.088 DBMET03686 0.225 0.103 DBMET03688 0.477 0.031 DBMET03685 0.244 0.092 DBMET03687 0.205 0.117 DBMET03689 | DBMET03685 | |
| 0.02 | 0.051 | 0.038 | Purinergic P2Y15 antagonist | 0.027 0.024 DBMET03683 0.038 0.008 DBMET03684 0.038 0.008 DBMET03685 | DBMET03685 | |
| 0.01 | 0.042 | 0.017 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET03684 0.017 0.009 DBMET03686 0.015 0.011 DBMET03688 0.016 0.01 DBMET03685 | DBMET03686 | |
| 0.017 | 0.051 | 0.028 | Vanilloid 2 agonist | 0.023 0.022 DBMET03682 0.028 0.013 DBMET03684 0.025 0.019 DBMET03688 0.028 0.013 DBMET03685 0.027 0.015 DBMET03687 0.025 0.019 DBMET03689 | DBMET03685 | |
| 0.005 | 0.04 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET03684 0.013 0.01 DBMET03685 | DBMET03685 | |
| 0.007 | 0.043 | 0.054 | Aminopeptidase A inhibitor | 0.04 0.004 DBMET03686 0.039 0.005 DBMET03688 0.054 0.003 DBMET03690 0.023 0.009 DBMET03687 0.02 0.01 DBMET03689 | DBMET03690 | |
| 0.091 | 0.127 | 0.167 | Cathepsin H inhibitor | 0.13 0.064 DBMET03682 0.109 0.091 DBMET03683 0.162 0.038 DBMET03684 0.156 0.042 DBMET03686 0.167 0.036 DBMET03688 0.136 0.057 DBMET03690 0.162 0.038 DBMET03685 0.146 0.049 DBMET03687 0.132 0.061 DBMET03689 | DBMET03688 | |
| 0.016 | 0.053 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET03682 0.025 0.018 DBMET03684 0.025 0.018 DBMET03685 0.026 0.015 DBMET03687 0.024 0.019 DBMET03689 | DBMET03687 | |
| 0.075 | 0.111 | 0.205 | Electrolyte absorption antagonist | 0.136 0.026 DBMET03682 0.14 0.024 DBMET03684 0.103 0.054 DBMET03686 0.09 0.073 DBMET03688 0.14 0.024 DBMET03685 0.205 0.008 DBMET03687 0.182 0.011 DBMET03689 | DBMET03687 | |
| 0.013 | 0.05 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET03682 0.017 0.015 DBMET03684 0.017 0.016 DBMET03686 0.017 0.015 DBMET03685 0.02 0.009 DBMET03687 0.019 0.011 DBMET03689 | DBMET03687 | |
| 0.017 | 0.055 | 0.241 | Glutamate (mGluR1) agonist | 0.039 0.005 DBMET03682 0.035 0.007 DBMET03684 0.209 0.002 DBMET03686 0.241 0.002 DBMET03688 0.028 0.011 DBMET03690 0.035 0.007 DBMET03685 0.11 0.004 DBMET03687 0.084 0.004 DBMET03689 | DBMET03688 | |
| 0.095 | 0.134 | 0.681 | Peroxidase inhibitor | 0.248 0.048 DBMET03682 0.273 0.043 DBMET03684 0.57 0.005 DBMET03686 0.527 0.008 DBMET03688 0.681 0.003 DBMET03690 0.273 0.043 DBMET03685 0.232 0.051 DBMET03687 0.179 0.066 DBMET03689 | DBMET03690 | |
| 0.024 | 0.063 | 0.074 | Glutamate (mGluR3) agonist | 0.042 0.009 DBMET03682 0.036 0.014 DBMET03684 0.056 0.004 DBMET03686 0.074 0.003 DBMET03688 0.031 0.026 DBMET03690 0.036 0.014 DBMET03685 0.068 0.003 DBMET03687 0.061 0.004 DBMET03689 | DBMET03688 | |
| 0.016 | 0.056 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 DBMET03684 0.027 0.018 DBMET03685 0.033 0.009 DBMET03687 0.029 0.014 DBMET03689 | DBMET03687 | |
| 0.032 | 0.072 | 0.085 | DNA gyrase subunit A inhibitor | 0.04 0.036 DBMET03684 0.04 0.036 DBMET03685 0.085 0.005 DBMET03687 0.077 0.005 DBMET03689 | DBMET03687 | |
| 0.036 | 0.077 | 0.08 | Baculoviral IAP repeat-containing protein inhibitor | 0.069 0.004 DBMET03682 0.056 0.009 DBMET03683 0.08 0.004 DBMET03684 | DBMET03684 | |
| 0.014 | 0.056 | 0.111 | Lysine carboxypeptidase inhibitor | 0.033 0.014 DBMET03682 0.026 0.02 DBMET03684 0.087 0.004 DBMET03686 0.111 0.004 DBMET03688 0.095 0.004 DBMET03690 0.026 0.02 DBMET03685 0.047 0.008 DBMET03687 0.041 0.01 DBMET03689 | DBMET03688 | |
| 0.019 | 0.063 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 DBMET03684 0.028 0.018 DBMET03686 0.027 0.02 DBMET03688 0.028 0.017 DBMET03690 0.026 0.021 DBMET03685 0.027 0.02 DBMET03687 0.025 0.024 DBMET03689 | DBMET03690 | |
| 0.124 | 0.168 | 0.435 | Aldehyde oxidase inhibitor | 0.34 0.057 DBMET03682 0.365 0.052 DBMET03684 0.32 0.061 DBMET03686 0.271 0.075 DBMET03688 0.365 0.052 DBMET03685 0.435 0.042 DBMET03687 0.349 0.055 DBMET03689 | DBMET03687 | |
| 0.013 | 0.059 | 0.032 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET03684 0.021 0.014 DBMET03685 0.032 0.004 DBMET03687 0.029 0.005 DBMET03689 | DBMET03687 | |
| 0.004 | 0.051 | 0.015 | Thromboxane agonist | 0.011 0.007 DBMET03682 0.015 0.005 DBMET03687 0.012 0.006 DBMET03689 | DBMET03687 | |
| 0.03 | 0.078 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 DBMET03682 0.046 0.02 DBMET03684 0.046 0.02 DBMET03685 0.054 0.011 DBMET03687 0.05 0.015 DBMET03689 | DBMET03687 | |
| 0.007 | 0.056 | 0.023 | NMDA receptor phencyclidine site antagonist | 0.023 0.006 DBMET03684 0.023 0.006 DBMET03685 | DBMET03685 | |
| 0.017 | 0.068 | 0.072 | Calcitonin receptor agonist | 0.037 0.021 DBMET03686 0.035 0.023 DBMET03688 0.072 0.013 DBMET03690 0.04 0.02 DBMET03687 0.036 0.022 DBMET03689 | DBMET03690 | |
| 0.022 | 0.072 | 0.051 | Carboxypeptidase B inhibitor | 0.036 0.017 DBMET03682 0.033 0.023 DBMET03684 0.048 0.007 DBMET03686 0.051 0.006 DBMET03688 0.048 0.008 DBMET03690 0.033 0.023 DBMET03685 0.037 0.016 DBMET03687 0.035 0.02 DBMET03689 | DBMET03688 | |
| 0.036 | 0.087 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.07 0.026 DBMET03682 0.077 0.022 DBMET03684 0.077 0.022 DBMET03685 0.055 0.04 DBMET03687 0.05 0.049 DBMET03689 | DBMET03685 | |
| 0.02 | 0.072 | 0.034 | Hedgehog signaling activator | 0.034 0.008 DBMET03684 0.034 0.008 DBMET03685 | DBMET03685 | |
| 0.043 | 0.095 | 0.314 | Catalase inhibitor | 0.194 0.016 DBMET03682 0.098 0.039 DBMET03684 0.314 0.005 DBMET03686 0.293 0.006 DBMET03688 0.265 0.008 DBMET03690 0.098 0.039 DBMET03685 0.15 0.026 DBMET03687 0.12 0.033 DBMET03689 | DBMET03686 | |
| 0.043 | 0.096 | 0.53 | Histidine decarboxylase inhibitor | 0.134 0.022 DBMET03682 0.1 0.032 DBMET03684 0.429 0.004 DBMET03686 0.38 0.004 DBMET03688 0.53 0.003 DBMET03690 0.1 0.032 DBMET03685 0.158 0.018 DBMET03687 0.126 0.024 DBMET03689 | DBMET03690 | |
| 0.071 | 0.124 | 0.162 | Cystathionine beta-synthase inhibitor | 0.152 0.04 DBMET03682 0.133 0.05 DBMET03684 0.162 0.036 DBMET03686 0.139 0.046 DBMET03688 0.133 0.05 DBMET03685 0.134 0.049 DBMET03687 0.117 0.061 DBMET03689 | DBMET03686 | |
| 0.009 | 0.063 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 DBMET03684 0.031 0.017 DBMET03685 | DBMET03685 | |
| 0.011 | 0.066 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.011 DBMET03684 0.02 0.011 DBMET03685 0.019 0.013 DBMET03687 0.018 0.017 DBMET03689 | DBMET03685 | |
| 0.008 | 0.063 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.018 0.011 DBMET03684 0.018 0.011 DBMET03685 0.022 0.007 DBMET03687 0.019 0.01 DBMET03689 | DBMET03687 | |
| 0.012 | 0.069 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET03682 0.021 0.019 DBMET03687 | DBMET03682 | |
| 0.003 | 0.061 | 0.013 | Carboxypeptidase B2 inhibitor | 0.013 0.007 DBMET03686 0.011 0.007 DBMET03688 | DBMET03686 | |
| 0.008 | 0.066 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 DBMET03684 0.019 0.008 DBMET03685 | DBMET03685 | |
| 0.036 | 0.095 | 0.1 | Acetylcholine M5 receptor agonist | 0.059 0.057 DBMET03683 0.1 0.02 DBMET03684 0.1 0.02 DBMET03685 0.059 0.057 DBMET03687 | DBMET03685 | |
| 0.012 | 0.071 | 0.039 | Nicotinic alpha4beta2 receptor agonist | 0.039 0.008 DBMET03684 0.039 0.008 DBMET03685 | DBMET03685 | |
| 0.033 | 0.094 | 0.062 | Topoisomerase II beta inhibitor | 0.046 0.041 DBMET03682 0.061 0.022 DBMET03684 0.061 0.022 DBMET03685 0.062 0.021 DBMET03687 0.053 0.029 DBMET03689 | DBMET03687 | |
| 0.031 | 0.092 | 0.053 | Aldosterone antagonist | 0.053 0.025 DBMET03684 0.053 0.025 DBMET03685 0.043 0.041 DBMET03687 | DBMET03685 | |
| 0.04 | 0.102 | 0.369 | Phenylalanine 4-hydroxylase inhibitor | 0.109 0.022 DBMET03682 0.086 0.033 DBMET03684 0.369 0.003 DBMET03686 0.235 0.005 DBMET03688 0.074 0.043 DBMET03690 0.086 0.033 DBMET03685 0.127 0.016 DBMET03687 0.109 0.022 DBMET03689 | DBMET03686 | |
| 0.062 | 0.125 | 0.095 | MAP kinase kinase 7 inhibitor | 0.078 0.052 DBMET03682 0.073 0.068 DBMET03683 0.095 0.017 DBMET03684 0.095 0.017 DBMET03685 0.089 0.025 DBMET03687 0.084 0.035 DBMET03689 | DBMET03685 | |
| 0.076 | 0.14 | 0.145 | Microtubule formation inhibitor | 0.108 0.077 DBMET03682 0.124 0.057 DBMET03684 0.117 0.064 DBMET03686 0.098 0.094 DBMET03688 0.124 0.057 DBMET03685 0.145 0.04 DBMET03687 0.13 0.051 DBMET03689 | DBMET03687 | |
| 0.05 | 0.114 | 0.127 | GABA aminotransferase inhibitor | 0.096 0.03 DBMET03682 0.087 0.038 DBMET03684 0.105 0.023 DBMET03686 0.098 0.029 DBMET03688 0.087 0.038 DBMET03685 0.127 0.013 DBMET03687 0.113 0.019 DBMET03689 | DBMET03687 | |
| 0.026 | 0.091 | 0.057 | Nerve growth factor antagonist | 0.054 0.014 DBMET03684 0.054 0.014 DBMET03685 0.057 0.012 DBMET03687 0.051 0.017 DBMET03689 | DBMET03687 | |
| 0.066 | 0.132 | 0.206 | DNA intercalator | 0.206 0.024 DBMET03687 0.165 0.037 DBMET03689 | DBMET03687 | |
| 0.012 | 0.081 | 0.024 | Retinoid X beta receptor antagonist | 0.021 0.012 DBMET03682 0.024 0.008 DBMET03687 0.022 0.011 DBMET03689 | DBMET03687 | |
| 0.046 | 0.116 | 0.096 | Phospholipase D inhibitor | 0.079 0.036 DBMET03682 0.096 0.017 DBMET03684 0.07 0.054 DBMET03686 0.096 0.017 DBMET03685 0.079 0.036 DBMET03687 0.071 0.05 DBMET03689 | DBMET03685 | |
| 0.011 | 0.082 | 0.02 | Caspase 8 inhibitor | 0.02 0.014 DBMET03690 0.02 0.014 DBMET03687 | DBMET03687 | |
| 0.033 | 0.108 | 0.115 | Bombesin 2 receptor antagonist | 0.045 0.041 DBMET03684 0.05 0.033 DBMET03686 0.047 0.038 DBMET03688 0.115 0.013 DBMET03690 0.045 0.041 DBMET03685 0.05 0.033 DBMET03687 0.046 0.039 DBMET03689 | DBMET03690 | |
| 0.018 | 0.094 | 0.059 | Oxytocin agonist | 0.048 0.025 DBMET03684 0.039 0.033 DBMET03688 0.059 0.018 DBMET03690 0.048 0.025 DBMET03685 0.051 0.023 DBMET03687 0.056 0.02 DBMET03689 | DBMET03690 | |
| 0.043 | 0.12 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | 0.115 0.02 DBMET03684 0.115 0.02 DBMET03685 0.089 0.041 DBMET03687 0.074 0.057 DBMET03689 | DBMET03685 | |
| 0.094 | 0.172 | 0.163 | Vanilloid 1 agonist | 0.142 0.048 DBMET03682 0.131 0.064 DBMET03684 0.116 0.098 DBMET03686 0.124 0.079 DBMET03688 0.163 0.027 DBMET03690 0.115 0.099 DBMET03685 0.117 0.096 DBMET03687 | DBMET03690 | |
| 0.068 | 0.148 | 0.27 | Mucolytic | 0.137 0.041 DBMET03682 0.119 0.055 DBMET03684 0.264 0.005 DBMET03686 0.197 0.014 DBMET03688 0.219 0.01 DBMET03690 0.119 0.055 DBMET03685 0.247 0.007 DBMET03687 0.27 0.005 DBMET03689 | DBMET03689 | |
| 0.065 | 0.145 | 0.091 | Estrogen-related receptor beta agonist | 0.084 0.055 DBMET03682 0.091 0.038 DBMET03684 0.091 0.038 DBMET03685 0.078 0.075 DBMET03687 | DBMET03685 | |
| 0.024 | 0.105 | 0.039 | Adenosine uptake inhibitor | 0.039 0.014 DBMET03684 0.039 0.014 DBMET03685 | DBMET03685 | |
| 0.018 | 0.099 | 0.228 | Toll-Like receptor 2 agonist | 0.035 0.034 DBMET03682 0.1 0.015 DBMET03686 0.13 0.012 DBMET03688 0.228 0.005 DBMET03690 0.038 0.031 DBMET03687 | DBMET03690 | |
| 0.009 | 0.091 | 0.037 | Acetylcholine M4 receptor agonist | 0.037 0.016 DBMET03684 0.037 0.016 DBMET03685 | DBMET03685 | |
| 0.04 | 0.122 | 0.066 | Pregnane X receptor antagonist | 0.056 0.041 DBMET03682 0.066 0.019 DBMET03684 0.066 0.019 DBMET03685 0.061 0.028 DBMET03687 0.057 0.039 DBMET03689 | DBMET03685 | |
| 0.021 | 0.11 | 0.061 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 DBMET03682 0.041 0.014 DBMET03684 0.061 0.004 DBMET03686 0.051 0.005 DBMET03688 0.041 0.014 DBMET03685 0.06 0.004 DBMET03687 0.054 0.004 DBMET03689 | DBMET03686 | |
| 0.047 | 0.136 | 0.067 | Exportin-1 inhibitor | 0.067 0.051 DBMET03684 0.067 0.051 DBMET03685 | DBMET03685 | |
| 0.013 | 0.102 | 0.044 | Peptide deformylase inhibitor | 0.033 0.018 DBMET03684 0.028 0.024 DBMET03688 0.044 0.012 DBMET03690 0.033 0.018 DBMET03685 | DBMET03690 | |
| 0.04 | 0.13 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | 0.072 0.035 DBMET03690 | DBMET03690 | |
| 0.053 | 0.144 | 0.087 | Vanilloid 4 agonist | 0.069 0.068 DBMET03682 0.087 0.03 DBMET03684 0.087 0.03 DBMET03685 | DBMET03685 | |
| 0.117 | 0.209 | 0.249 | Neurotensin receptor agonist | 0.174 0.056 DBMET03682 0.169 0.063 DBMET03684 0.213 0.029 DBMET03686 0.202 0.033 DBMET03688 0.249 0.021 DBMET03690 0.169 0.063 DBMET03685 0.183 0.047 DBMET03687 0.171 0.061 DBMET03689 | DBMET03690 | |
| 0.008 | 0.102 | 0.018 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET03687 | DBMET03687 | |
| 0.006 | 0.1 | 0.018 | Neurokinin 1 agonist | 0.018 0.016 DBMET03690 | DBMET03690 | |
| 0.064 | 0.159 | 0.103 | CC chemokine 5 receptor agonist | 0.078 0.07 DBMET03683 0.103 0.019 DBMET03684 0.103 0.019 DBMET03685 0.082 0.058 DBMET03687 | DBMET03685 | |
| 0.047 | 0.142 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 DBMET03684 0.087 0.026 DBMET03685 | DBMET03685 | |
| 0.042 | 0.138 | 0.097 | Glutamate (mGluR7) antagonist | 0.075 0.034 DBMET03682 0.078 0.029 DBMET03684 0.087 0.02 DBMET03686 0.093 0.015 DBMET03688 0.078 0.029 DBMET03685 0.097 0.012 DBMET03687 0.089 0.018 DBMET03689 | DBMET03687 | |
| 0.014 | 0.112 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.021 DBMET03682 0.037 0.014 DBMET03684 0.037 0.014 DBMET03685 0.028 0.025 DBMET03687 | DBMET03685 | |
| 0.018 | 0.116 | 0.059 | GABA uptake inhibitor | 0.037 0.031 DBMET03682 0.04 0.026 DBMET03684 0.04 0.026 DBMET03685 0.059 0.01 DBMET03687 0.051 0.015 DBMET03689 | DBMET03687 | |
| 0.048 | 0.147 | 0.108 | Keratolytic | 0.079 0.05 DBMET03682 0.075 0.056 DBMET03684 0.085 0.043 DBMET03686 0.073 0.06 DBMET03688 0.075 0.056 DBMET03685 0.108 0.026 DBMET03687 0.095 0.034 DBMET03689 | DBMET03687 | |
| 0.017 | 0.117 | 0.073 | Antimetabolite | 0.044 0.036 DBMET03682 0.057 0.027 DBMET03686 0.064 0.024 DBMET03688 0.073 0.021 DBMET03690 | DBMET03690 | |
| 0.043 | 0.142 | 0.139 | Ornithine decarboxylase inhibitor | 0.087 0.06 DBMET03682 0.08 0.068 DBMET03684 0.125 0.022 DBMET03686 0.139 0.015 DBMET03688 0.086 0.061 DBMET03690 0.08 0.068 DBMET03685 0.122 0.024 DBMET03687 0.113 0.031 DBMET03689 | DBMET03688 | |
| 0.004 | 0.105 | 0.035 | Nociceptin (N/OFQ) receptor agonist | 0.035 0.009 DBMET03684 0.035 0.009 DBMET03685 0.023 0.013 DBMET03687 | DBMET03685 | |
| 0.024 | 0.126 | 0.066 | Adenylate cyclase 1 inhibitor | 0.066 0.014 DBMET03684 0.066 0.014 DBMET03685 | DBMET03685 | |
| 0.022 | 0.125 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.032 DBMET03684 0.043 0.032 DBMET03685 0.049 0.025 DBMET03687 0.042 0.033 DBMET03689 | DBMET03687 | |
| 0.072 | 0.177 | 0.136 | Acetylcholine release stimulant | 0.136 0.027 DBMET03684 0.136 0.027 DBMET03685 0.124 0.042 DBMET03687 0.112 0.061 DBMET03689 | DBMET03685 | |
| 0.017 | 0.123 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET03684 0.026 0.019 DBMET03685 | DBMET03685 | |
| 0.014 | 0.121 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.021 DBMET03684 0.028 0.021 DBMET03685 | DBMET03685 | |
| 0.016 | 0.124 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 DBMET03684 0.03 0.015 DBMET03685 | DBMET03685 | |
| 0.024 | 0.132 | 0.088 | Prolyl endopeptidase inhibitor | 0.054 0.031 DBMET03684 0.054 0.031 DBMET03685 0.088 0.009 DBMET03687 0.079 0.011 DBMET03689 | DBMET03687 | |
| 0.148 | 0.257 | 0.405 | Insulysin inhibitor | 0.26 0.087 DBMET03682 0.262 0.086 DBMET03684 0.323 0.046 DBMET03686 0.307 0.054 DBMET03688 0.405 0.021 DBMET03690 0.262 0.086 DBMET03685 0.346 0.035 DBMET03687 0.329 0.043 DBMET03689 | DBMET03690 | |
| 0.033 | 0.142 | 0.061 | Dihydroorotate oxidase inhibitor | 0.06 0.028 DBMET03684 0.06 0.028 DBMET03685 0.061 0.028 DBMET03687 0.055 0.038 DBMET03689 | DBMET03687 | |
| 0.028 | 0.137 | 0.067 | Androgen agonist | 0.067 0.033 DBMET03684 0.067 0.033 DBMET03685 0.062 0.039 DBMET03687 0.053 0.052 DBMET03689 | DBMET03685 | |
| 0.026 | 0.136 | 0.118 | Glutamate (mGluR4) antagonist | 0.055 0.017 DBMET03682 0.049 0.021 DBMET03684 0.099 0.005 DBMET03686 0.114 0.005 DBMET03688 0.043 0.03 DBMET03690 0.049 0.021 DBMET03685 0.118 0.004 DBMET03687 0.1 0.005 DBMET03689 | DBMET03687 | |
| 0.01 | 0.12 | 0.04 | 5-Alpha-reductase inhibitor | 0.04 0.024 DBMET03687 | DBMET03687 | |
| 0.023 | 0.132 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET03682 0.05 0.036 DBMET03684 0.048 0.039 DBMET03686 0.045 0.044 DBMET03688 0.058 0.025 DBMET03690 0.05 0.036 DBMET03685 0.054 0.029 DBMET03687 0.049 0.038 DBMET03689 | DBMET03690 | |
| 0.027 | 0.137 | 0.079 | Cyclin-dependent kinase 6 inhibitor | 0.079 0.023 DBMET03684 0.079 0.023 DBMET03685 | DBMET03685 | |
| 0.016 | 0.127 | 0.033 | Dipeptidyl peptidase II inhibitor | 0.03 0.027 DBMET03684 0.029 0.028 DBMET03686 0.032 0.024 DBMET03688 0.031 0.024 DBMET03690 0.03 0.027 DBMET03685 0.033 0.022 DBMET03687 | DBMET03687 | |
| 0.051 | 0.162 | 0.297 | Expectorant | 0.118 0.052 DBMET03682 0.102 0.066 DBMET03684 0.29 0.009 DBMET03686 0.199 0.021 DBMET03688 0.229 0.015 DBMET03690 0.102 0.066 DBMET03685 0.265 0.011 DBMET03687 0.297 0.009 DBMET03689 | DBMET03689 | |
| 0.019 | 0.131 | 0.043 | Histamine H2 receptor agonist | 0.043 0.029 DBMET03684 0.043 0.029 DBMET03685 | DBMET03685 | |
| 0.005 | 0.118 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 DBMET03684 0.016 0.015 DBMET03685 | DBMET03685 | |
| 0.118 | 0.231 | 0.25 | DNA damaging | 0.196 0.118 DBMET03682 0.192 0.122 DBMET03684 0.25 0.08 DBMET03687 0.204 0.112 DBMET03689 | DBMET03687 | |
| 0.12 | 0.237 | 0.269 | 5 Hydroxytryptamine 1E antagonist | 0.189 0.144 DBMET03683 0.269 0.055 DBMET03684 0.269 0.055 DBMET03685 0.233 0.093 DBMET03687 0.209 0.121 DBMET03689 | DBMET03685 | |
| 0.033 | 0.152 | 0.233 | NMDA receptor agonist | 0.076 0.031 DBMET03682 0.059 0.049 DBMET03684 0.208 0.004 DBMET03686 0.233 0.004 DBMET03688 0.114 0.015 DBMET03690 0.059 0.049 DBMET03685 0.179 0.005 DBMET03687 0.155 0.007 DBMET03689 | DBMET03688 | |
| 0.026 | 0.146 | 0.071 | HCV NS3/NS4A protease inhibitor | 0.049 0.034 DBMET03684 0.046 0.041 DBMET03686 0.046 0.04 DBMET03688 0.071 0.014 DBMET03690 0.049 0.034 DBMET03685 0.059 0.022 DBMET03687 0.054 0.028 DBMET03689 | DBMET03690 | |
| 0.048 | 0.169 | 0.124 | HIV-1 integrase (Overall Integration) inhibitor | 0.124 0.037 DBMET03682 0.109 0.047 DBMET03684 0.082 0.076 DBMET03686 0.109 0.047 DBMET03685 0.105 0.05 DBMET03687 0.089 0.066 DBMET03689 | DBMET03682 | |
| 0.021 | 0.142 | 0.046 | 5 Hydroxytryptamine 2B agonist | 0.046 0.016 DBMET03684 0.046 0.016 DBMET03685 | DBMET03685 | |
| 0.029 | 0.151 | 0.083 | Sphingosine kinase 2 inhibitor | 0.083 0.014 DBMET03684 0.083 0.014 DBMET03685 0.065 0.026 DBMET03687 0.056 0.036 DBMET03689 | DBMET03685 | |
| 0.022 | 0.147 | 0.043 | Histamine H1 receptor agonist | 0.043 0.033 DBMET03684 0.043 0.033 DBMET03685 | DBMET03685 | |
| 0.026 | 0.152 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.035 DBMET03684 0.048 0.035 DBMET03685 | DBMET03685 | |
| 0.028 | 0.155 | 0.05 | Potassium channel (Inward rectifier) activator | 0.05 0.036 DBMET03684 0.05 0.036 DBMET03685 | DBMET03685 | |
| 0.017 | 0.146 | 0.058 | Thymidylate synthase inhibitor | 0.045 0.035 DBMET03688 0.058 0.019 DBMET03690 | DBMET03690 | |
| 0.032 | 0.162 | 0.073 | Purinergic P2X1 antagonist | 0.055 0.052 DBMET03682 0.062 0.041 DBMET03684 0.062 0.041 DBMET03685 0.073 0.029 DBMET03687 0.064 0.038 DBMET03689 | DBMET03687 | |
| 0.119 | 0.249 | 0.19 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.17 0.108 DBMET03682 0.19 0.081 DBMET03684 0.19 0.081 DBMET03685 0.19 0.082 DBMET03687 0.171 0.107 DBMET03689 | DBMET03687 | |
| 0.033 | 0.163 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.045 DBMET03684 0.058 0.045 DBMET03685 0.067 0.03 DBMET03687 0.058 0.045 DBMET03689 | DBMET03687 | |
| 0.01 | 0.141 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 DBMET03684 0.02 0.016 DBMET03685 | DBMET03685 | |
| 0.011 | 0.144 | 0.051 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.025 DBMET03682 0.033 0.025 DBMET03684 0.033 0.025 DBMET03685 0.051 0.007 DBMET03687 0.045 0.011 DBMET03689 | DBMET03687 | |
| 0.021 | 0.155 | 0.122 | NMDA receptor glycine site agonist | 0.065 0.04 DBMET03682 0.072 0.035 DBMET03686 0.074 0.033 DBMET03688 0.122 0.008 DBMET03687 0.111 0.012 DBMET03689 | DBMET03687 | |
| 0.011 | 0.145 | 0.044 | Retinoid X alpha receptor agonist | 0.044 0.017 DBMET03687 0.036 0.023 DBMET03689 | DBMET03687 | |
| 0.017 | 0.151 | 0.038 | Retinoid X alpha receptor antagonist | 0.032 0.028 DBMET03682 0.038 0.018 DBMET03687 0.034 0.024 DBMET03689 | DBMET03687 | |
| 0.039 | 0.173 | 0.069 | Ryanodine receptor antagonist | 0.057 0.048 DBMET03684 0.057 0.048 DBMET03685 0.069 0.018 DBMET03687 0.064 0.027 DBMET03689 | DBMET03687 | |
| 0.104 | 0.24 | 0.498 | Phospholipase C inhibitor | 0.173 0.069 DBMET03682 0.173 0.069 DBMET03684 0.385 0.011 DBMET03686 0.418 0.009 DBMET03688 0.498 0.006 DBMET03690 0.173 0.069 DBMET03685 0.291 0.019 DBMET03687 0.247 0.026 DBMET03689 | DBMET03690 | |
| 0.019 | 0.156 | 0.043 | Retinoid X receptor antagonist | 0.036 0.031 DBMET03682 0.043 0.019 DBMET03687 0.038 0.026 DBMET03689 | DBMET03687 | |
| 0.039 | 0.176 | 0.14 | Histamine N-methyltransferase inhibitor | 0.111 0.037 DBMET03684 0.098 0.047 DBMET03686 0.14 0.018 DBMET03688 0.111 0.037 DBMET03685 0.08 0.067 DBMET03687 | DBMET03688 | |
| 0.007 | 0.145 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 DBMET03687 | DBMET03687 | |
| 0.01 | 0.148 | 0.052 | Carnitine palmitoyltransferase inhibitor | 0.033 0.025 DBMET03682 0.033 0.025 DBMET03684 0.033 0.025 DBMET03685 0.052 0.007 DBMET03687 0.046 0.011 DBMET03689 | DBMET03687 | |
| 0.008 | 0.149 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.009 DBMET03687 0.018 0.013 DBMET03689 | DBMET03687 | |
| 0.012 | 0.154 | 0.036 | Integrin alpha2beta1 antagonist | 0.036 0.008 DBMET03687 0.032 0.01 DBMET03689 | DBMET03687 | |
| 0.008 | 0.15 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 DBMET03686 0.023 0.014 DBMET03688 | DBMET03688 | |
| 0.061 | 0.205 | 0.117 | Glutamate (mGluR7) agonist | 0.092 0.079 DBMET03682 0.109 0.044 DBMET03684 0.107 0.046 DBMET03686 0.117 0.033 DBMET03688 0.109 0.044 DBMET03685 0.095 0.071 DBMET03687 | DBMET03688 | |
| 0.037 | 0.182 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.08 0.034 DBMET03684 0.08 0.034 DBMET03685 0.069 0.066 DBMET03687 | DBMET03685 | |
| 0.03 | 0.176 | 0.078 | 5 Hydroxytryptamine 3 agonist | 0.078 0.028 DBMET03684 0.078 0.028 DBMET03685 | DBMET03685 | |
| 0.063 | 0.209 | 0.11 | Photosensitizer | 0.099 0.09 DBMET03688 0.11 0.071 DBMET03687 0.099 0.09 DBMET03689 | DBMET03687 | |
| 0.112 | 0.259 | 0.17 | Heat shock protein 70 antagonist | 0.133 0.106 DBMET03682 0.141 0.073 DBMET03684 0.131 0.115 DBMET03686 0.141 0.073 DBMET03685 0.17 0.018 DBMET03687 0.16 0.027 DBMET03689 | DBMET03687 | |
| 0.021 | 0.168 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.035 DBMET03684 0.054 0.035 DBMET03685 0.06 0.029 DBMET03687 0.052 0.04 DBMET03689 | DBMET03687 | |
| 0.048 | 0.197 | 0.107 | Cholesterol synthesis inhibitor | 0.1 0.087 DBMET03682 0.107 0.078 DBMET03687 0.095 0.094 DBMET03689 | DBMET03687 | |
| 0.02 | 0.17 | 0.04 | Thymidine kinase inhibitor | 0.04 0.029 DBMET03684 0.04 0.029 DBMET03685 | DBMET03685 | |
| 0.025 | 0.175 | 0.11 | Carbonic anhydrase stimulant | 0.054 0.048 DBMET03682 0.052 0.05 DBMET03684 0.075 0.029 DBMET03686 0.069 0.032 DBMET03688 0.11 0.016 DBMET03690 0.052 0.05 DBMET03685 | DBMET03690 | |
| 0.02 | 0.169 | 0.044 | AICAR transformylase inhibitor | 0.041 0.037 DBMET03682 0.042 0.035 DBMET03686 0.044 0.03 DBMET03690 | DBMET03690 | |
| 0.034 | 0.186 | 0.105 | Acetylcholine M3 receptor agonist | 0.105 0.042 DBMET03684 0.105 0.042 DBMET03685 0.08 0.06 DBMET03687 | DBMET03685 | |
| 0.015 | 0.168 | 0.056 | Adenosine deaminase inhibitor | 0.042 0.039 DBMET03684 0.056 0.025 DBMET03686 0.049 0.031 DBMET03688 0.042 0.039 DBMET03685 0.048 0.032 DBMET03687 | DBMET03686 | |
| 0.014 | 0.169 | 0.09 | Glutamate (mGluR3) antagonist | 0.042 0.019 DBMET03682 0.033 0.031 DBMET03684 0.067 0.006 DBMET03686 0.09 0.005 DBMET03688 0.033 0.031 DBMET03685 0.078 0.005 DBMET03687 0.064 0.007 DBMET03689 | DBMET03688 | |
| 0.056 | 0.211 | 0.105 | Carbonic anhydrase XV inhibitor | 0.105 0.06 DBMET03687 0.094 0.077 DBMET03689 | DBMET03687 | |
| 0.033 | 0.189 | 0.064 | Phosphodiesterase 1A inhibitor | 0.064 0.033 DBMET03684 0.064 0.033 DBMET03685 | DBMET03685 | |
| 0.03 | 0.187 | 0.101 | Cathepsin G inhibitor | 0.073 0.05 DBMET03686 0.065 0.06 DBMET03688 0.074 0.049 DBMET03690 0.101 0.033 DBMET03687 0.085 0.041 DBMET03689 | DBMET03687 | |
| 0.002 | 0.159 | 0.04 | Prostaglandin EP4 agonist | 0.028 0.007 DBMET03687 0.04 0.006 DBMET03689 | DBMET03689 | |
| 0.085 | 0.241 | 0.141 | Melanin inhibitor | 0.127 0.12 DBMET03684 0.127 0.12 DBMET03685 0.141 0.094 DBMET03687 0.131 0.112 DBMET03689 | DBMET03687 | |
| 0.076 | 0.234 | 0.296 | Anesthetic general | 0.193 0.078 DBMET03682 0.229 0.06 DBMET03684 0.178 0.088 DBMET03686 0.155 0.108 DBMET03688 0.229 0.06 DBMET03685 0.296 0.034 DBMET03687 0.255 0.048 DBMET03689 | DBMET03687 | |
| 0.009 | 0.168 | 0.047 | Nicotinic acid receptor agonist | 0.047 0.016 DBMET03687 0.036 0.024 DBMET03689 | DBMET03687 | |
| 0.032 | 0.192 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET03684 0.07 0.028 DBMET03685 | DBMET03685 | |
| 0.09 | 0.251 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.064 DBMET03682 0.163 0.042 DBMET03684 0.162 0.043 DBMET03686 0.154 0.054 DBMET03688 0.163 0.042 DBMET03685 0.204 0.01 DBMET03687 0.192 0.015 DBMET03689 | DBMET03687 | |
| 0.142 | 0.305 | 0.434 | Histamine release inhibitor | 0.289 0.13 DBMET03682 0.29 0.129 DBMET03684 0.324 0.112 DBMET03686 0.385 0.083 DBMET03688 0.434 0.058 DBMET03690 0.29 0.129 DBMET03685 0.406 0.073 DBMET03687 0.357 0.096 DBMET03689 | DBMET03690 | |
| 0.007 | 0.17 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 DBMET03687 | DBMET03687 | |
| 0.06 | 0.224 | 0.24 | Toll-Like receptor 2 antagonist | 0.111 0.088 DBMET03682 0.11 0.089 DBMET03684 0.171 0.039 DBMET03686 0.16 0.046 DBMET03688 0.24 0.011 DBMET03690 0.11 0.089 DBMET03685 0.106 0.095 DBMET03687 | DBMET03690 | |
| 0.012 | 0.177 | 0.042 | Alpha 1d adrenoreceptor agonist | 0.042 0.023 DBMET03684 0.042 0.023 DBMET03685 | DBMET03685 | |
| 0.023 | 0.193 | 0.112 | Glutamate (mGluR group III) antagonist | 0.047 0.024 DBMET03682 0.042 0.033 DBMET03684 0.075 0.008 DBMET03686 0.092 0.006 DBMET03688 0.042 0.033 DBMET03685 0.112 0.005 DBMET03687 0.09 0.006 DBMET03689 | DBMET03687 | |
| 0.093 | 0.262 | 0.172 | Neurotrophic factor enhancer | 0.172 0.108 DBMET03684 0.172 0.108 DBMET03685 0.155 0.13 DBMET03687 | DBMET03685 | |
| 0.023 | 0.195 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 DBMET03684 0.05 0.031 DBMET03685 0.049 0.033 DBMET03687 | DBMET03685 | |
| 0.036 | 0.209 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.032 DBMET03684 0.057 0.032 DBMET03685 | DBMET03685 | |
| 0.015 | 0.189 | 0.049 | Integrin alpha2 antagonist | 0.049 0.012 DBMET03687 0.044 0.016 DBMET03689 | DBMET03687 | |
| 0.01 | 0.184 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET03684 0.047 0.026 DBMET03685 0.044 0.03 DBMET03687 | DBMET03685 | |
| 0.004 | 0.18 | 0.032 | Prostaglandin EP2 agonist | 0.025 0.015 DBMET03687 0.032 0.011 DBMET03689 | DBMET03689 | |
| 0.016 | 0.196 | 0.095 | Dihydroorotase inhibitor | 0.095 0.006 DBMET03687 0.081 0.008 DBMET03689 | DBMET03687 | |
| 0.058 | 0.239 | 0.128 | Glutamate release inhibitor | 0.094 0.053 DBMET03684 0.094 0.053 DBMET03685 0.128 0.017 DBMET03687 0.115 0.025 DBMET03689 | DBMET03687 | |
| 0.064 | 0.246 | 0.177 | Protein kinase stimulant | 0.177 0.052 DBMET03687 0.154 0.065 DBMET03689 | DBMET03687 | |
| 0.008 | 0.19 | 0.039 | Acetylcholine M1 receptor agonist | 0.039 0.034 DBMET03684 0.039 0.034 DBMET03685 | DBMET03685 | |
| 0.048 | 0.233 | 0.095 | Carbonic anhydrase III inhibitor | 0.095 0.067 DBMET03687 | DBMET03687 | |
| 0.009 | 0.197 | 0.129 | Ribonucleoside-diphosphate reductase inhibitor | 0.054 0.038 DBMET03686 0.049 0.041 DBMET03688 0.129 0.014 DBMET03690 | DBMET03690 | |
| 0.008 | 0.197 | 0.125 | Ribonucleotide reductase inhibitor | 0.054 0.039 DBMET03686 0.049 0.043 DBMET03688 0.125 0.016 DBMET03690 | DBMET03690 | |
| 0.042 | 0.231 | 0.279 | Glutathione S-transferase inhibitor | 0.083 0.057 DBMET03682 0.094 0.043 DBMET03686 0.134 0.017 DBMET03688 0.279 0.003 DBMET03690 | DBMET03690 | |
| 0.052 | 0.241 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.076 DBMET03684 0.078 0.076 DBMET03685 | DBMET03685 | |
| 0.042 | 0.234 | 0.072 | Calcium channel P-type blocker | 0.065 0.04 DBMET03684 0.065 0.04 DBMET03685 0.072 0.024 DBMET03687 0.067 0.035 DBMET03689 | DBMET03687 | |
| 0.012 | 0.205 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.039 DBMET03690 0.044 0.04 DBMET03687 | DBMET03690 | |
| 0.035 | 0.228 | 0.137 | Falcipain 3 inhibitor | 0.116 0.056 DBMET03684 0.116 0.056 DBMET03685 0.137 0.043 DBMET03687 0.117 0.056 DBMET03689 | DBMET03687 | |
| 0.005 | 0.201 | 0.044 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 DBMET03686 0.044 0.011 DBMET03688 | DBMET03688 | |
| 0.035 | 0.232 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.06 DBMET03687 | DBMET03687 | |
| 0.02 | 0.219 | 0.049 | GABA B receptor antagonist | 0.039 0.037 DBMET03684 0.039 0.037 DBMET03685 0.049 0.02 DBMET03687 0.042 0.031 DBMET03689 | DBMET03687 | |
| 0.003 | 0.204 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET03690 | DBMET03690 | |
| 0.005 | 0.207 | 0.028 | HCV NS5A inhibitor | 0.028 0.019 DBMET03684 0.028 0.019 DBMET03685 | DBMET03685 | |
| 0.042 | 0.245 | 0.09 | GABA B receptor agonist | 0.075 0.055 DBMET03682 0.07 0.067 DBMET03684 0.078 0.045 DBMET03686 0.073 0.058 DBMET03688 0.07 0.067 DBMET03685 0.09 0.025 DBMET03687 0.083 0.037 DBMET03689 | DBMET03687 | |
| 0.1 | 0.304 | 0.209 | Transcription factor NF kappa B inhibitor | 0.205 0.164 DBMET03682 0.187 0.183 DBMET03684 0.196 0.173 DBMET03686 0.209 0.16 DBMET03688 0.204 0.165 DBMET03687 | DBMET03688 | |
| 0.036 | 0.242 | 0.105 | Sphingomyelinase inhibitor | 0.105 0.054 DBMET03684 0.105 0.054 DBMET03685 | DBMET03685 | |
| 0.022 | 0.228 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.028 DBMET03684 0.067 0.028 DBMET03685 0.058 0.042 DBMET03687 | DBMET03685 | |
| 0.026 | 0.233 | 0.098 | Anesthetic local | 0.098 0.085 DBMET03684 0.098 0.085 DBMET03685 0.098 0.085 DBMET03687 | DBMET03687 | |
| 0.019 | 0.227 | 0.085 | Neuronal nicotinic receptor antagonist | 0.066 0.049 DBMET03684 0.066 0.049 DBMET03685 0.085 0.033 DBMET03687 0.07 0.045 DBMET03689 | DBMET03687 | |
| 0.015 | 0.223 | 0.042 | Sphingosine kinase 1 inhibitor | 0.042 0.027 DBMET03684 0.042 0.027 DBMET03685 | DBMET03685 | |
| 0.006 | 0.215 | 0.036 | Free fatty acid receptor 1 antagonist | 0.036 0.02 DBMET03687 0.031 0.028 DBMET03689 | DBMET03687 | |
| 0.044 | 0.254 | 0.094 | Bromodomain-containing protein 2 inhibitor | 0.094 0.048 DBMET03684 0.094 0.048 DBMET03685 | DBMET03685 | |
| 0.03 | 0.241 | 0.059 | Interferon inducer | 0.059 0.056 DBMET03684 0.059 0.056 DBMET03685 | DBMET03685 | |
| 0.106 | 0.317 | 0.503 | Cholesterol antagonist | 0.274 0.108 DBMET03682 0.249 0.126 DBMET03684 0.268 0.113 DBMET03686 0.24 0.132 DBMET03688 0.249 0.126 DBMET03685 0.503 0.032 DBMET03687 0.442 0.042 DBMET03689 | DBMET03687 | |
| 0.019 | 0.231 | 0.06 | 5 Hydroxytryptamine 3A antagonist | 0.06 0.056 DBMET03684 0.06 0.056 DBMET03685 | DBMET03685 | |
| 0.003 | 0.215 | 0.036 | Kainate receptor 1 antagonist | 0.025 0.012 DBMET03686 0.036 0.008 DBMET03688 0.034 0.009 DBMET03687 0.025 0.012 DBMET03689 | DBMET03688 | |
| 0.01 | 0.223 | 0.052 | Acetylcholine muscarinic agonist | 0.052 0.041 DBMET03684 0.052 0.041 DBMET03685 | DBMET03685 | |
| 0.014 | 0.229 | 0.062 | AMPA 4 receptor antagonist | 0.051 0.015 DBMET03686 0.062 0.01 DBMET03688 0.052 0.014 DBMET03690 0.058 0.011 DBMET03687 0.049 0.015 DBMET03689 | DBMET03688 | |
| 0.01 | 0.227 | 0.073 | Nicotinic receptor beta4 subunit antagonist | 0.036 0.027 DBMET03684 0.036 0.027 DBMET03685 0.073 0.009 DBMET03687 0.064 0.011 DBMET03689 | DBMET03687 | |
| 0.005 | 0.224 | 0.031 | Dipeptidyl peptidase I inhibitor | 0.031 0.02 DBMET03684 0.031 0.02 DBMET03685 | DBMET03685 | |
| 0.014 | 0.234 | 0.075 | Glutamate (mGluR4) agonist | 0.039 0.017 DBMET03686 0.075 0.006 DBMET03688 | DBMET03688 | |
| 0.011 | 0.232 | 0.308 | Glycine transporter 2 inhibitor | 0.057 0.027 DBMET03686 0.12 0.01 DBMET03688 0.308 0.004 DBMET03690 | DBMET03690 | |
| 0.046 | 0.269 | 0.401 | Psychostimulant | 0.145 0.121 DBMET03682 0.193 0.084 DBMET03684 0.285 0.047 DBMET03686 0.401 0.022 DBMET03688 0.17 0.1 DBMET03690 0.193 0.084 DBMET03685 0.273 0.05 DBMET03687 0.22 0.07 DBMET03689 | DBMET03688 | |
| 0.042 | 0.267 | 0.075 | MDM2 inhibitor | 0.064 0.057 DBMET03682 0.066 0.052 DBMET03684 0.066 0.052 DBMET03685 0.075 0.027 DBMET03687 0.069 0.041 DBMET03689 | DBMET03687 | |
| 0.021 | 0.246 | 0.104 | Acetylcholine nicotinic antagonist | 0.078 0.057 DBMET03684 0.078 0.057 DBMET03685 0.104 0.037 DBMET03687 0.084 0.05 DBMET03689 | DBMET03687 | |
| 0.004 | 0.229 | 0.023 | NMDA receptor glycine site antagonist | 0.023 0.018 DBMET03687 | DBMET03687 | |
| 0.042 | 0.272 | 0.208 | Amylase inhibitor | 0.155 0.062 DBMET03686 0.208 0.041 DBMET03687 0.173 0.054 DBMET03689 | DBMET03687 | |
| 0.028 | 0.261 | 0.08 | Interferon agonist | 0.08 0.052 DBMET03687 0.071 0.068 DBMET03689 | DBMET03687 | |
| 0.031 | 0.264 | 0.053 | Leukotriene C antagonist | 0.053 0.052 DBMET03687 | DBMET03687 | |
| 0.097 | 0.332 | 0.326 | Gastrin inhibitor | 0.232 0.102 DBMET03682 0.238 0.094 DBMET03684 0.244 0.087 DBMET03686 0.223 0.114 DBMET03688 0.26 0.068 DBMET03690 0.238 0.094 DBMET03685 0.326 0.018 DBMET03687 0.309 0.027 DBMET03689 | DBMET03687 | |
| 0.026 | 0.261 | 0.051 | CD45 antagonist | 0.051 0.033 DBMET03690 0.051 0.033 DBMET03687 0.047 0.044 DBMET03689 | DBMET03687 | |
| 0.011 | 0.248 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.051 0.012 DBMET03687 0.041 0.018 DBMET03689 | DBMET03687 | |
| 0.018 | 0.255 | 0.068 | Protein kinase C beta inhibitor | 0.065 0.059 DBMET03684 0.065 0.059 DBMET03685 0.068 0.051 DBMET03687 | DBMET03687 | |
| 0.009 | 0.249 | 0.085 | NMDA 2A receptor antagonist | 0.062 0.028 DBMET03688 0.085 0.018 DBMET03690 0.06 0.029 DBMET03687 0.047 0.041 DBMET03689 | DBMET03690 | |
| 0.073 | 0.316 | 0.135 | 3C-like protease (Human coronavirus) inhibitor | 0.135 0.13 DBMET03684 0.135 0.13 DBMET03685 | DBMET03685 | |
| 0.005 | 0.251 | 0.048 | HCV NS5B polymerase inhibitor | 0.048 0.011 DBMET03687 0.039 0.015 DBMET03689 | DBMET03687 | |
| 0.005 | 0.254 | 0.033 | Prostaglandin agonist | 0.029 0.024 DBMET03687 0.033 0.018 DBMET03689 | DBMET03689 | |
| 0.044 | 0.297 | 0.219 | Thioredoxin reductase inhibitor | 0.203 0.004 DBMET03682 0.138 0.012 DBMET03683 0.219 0.004 DBMET03684 0.091 0.039 DBMET03686 0.085 0.049 DBMET03688 0.166 0.007 DBMET03687 0.15 0.009 DBMET03689 | DBMET03684 | |
| 0.02 | 0.276 | 0.054 | Dipeptidyl peptidase inhibitor | 0.052 0.039 DBMET03687 0.054 0.034 DBMET03689 | DBMET03689 | |
| 0.01 | 0.266 | 0.044 | Leukocyte elastase inhibitor | 0.044 0.029 DBMET03687 | DBMET03687 | |
| 0.042 | 0.299 | 0.138 | Adenylate cyclase inhibitor | 0.117 0.07 DBMET03684 0.121 0.067 DBMET03686 0.138 0.054 DBMET03688 0.124 0.064 DBMET03690 0.117 0.07 DBMET03685 0.125 0.063 DBMET03687 0.1 0.084 DBMET03689 | DBMET03688 | |
| 0.015 | 0.273 | 0.062 | 5 Hydroxytryptamine 2A agonist | 0.062 0.044 DBMET03684 0.062 0.044 DBMET03685 | DBMET03685 | |
| 0.052 | 0.31 | 0.337 | Cell wall synthesis inhibitor | 0.127 0.089 DBMET03682 0.143 0.073 DBMET03684 0.222 0.023 DBMET03686 0.199 0.03 DBMET03688 0.145 0.071 DBMET03690 0.143 0.073 DBMET03685 0.337 0.008 DBMET03687 0.3 0.01 DBMET03689 | DBMET03687 | |
| 0.006 | 0.265 | 0.082 | NMDA receptor subunit 3A antagonist | 0.063 0.016 DBMET03686 0.046 0.021 DBMET03688 0.082 0.011 DBMET03687 0.061 0.016 DBMET03689 | DBMET03687 | |
| 0.009 | 0.27 | 0.085 | NMDA 2C receptor antagonist | 0.059 0.046 DBMET03686 0.085 0.022 DBMET03688 0.07 0.033 DBMET03690 0.071 0.032 DBMET03687 0.06 0.045 DBMET03689 | DBMET03688 | |
| 0.005 | 0.266 | 0.055 | Kainate receptor 2 antagonist | 0.039 0.022 DBMET03686 0.055 0.014 DBMET03688 0.049 0.016 DBMET03687 0.038 0.024 DBMET03689 | DBMET03688 | |
| 0.012 | 0.273 | 0.05 | Acetylcholine M2 receptor agonist | 0.05 0.042 DBMET03684 0.05 0.042 DBMET03685 | DBMET03685 | |
| 0.003 | 0.265 | 0.023 | Prostaglandin E2 agonist | 0.023 0.017 DBMET03689 | DBMET03689 | |
| 0.005 | 0.268 | 0.034 | Farnesoid X receptor agonist | 0.034 0.031 DBMET03687 | DBMET03687 | |
| 0.039 | 0.302 | 0.165 | Proteasome inhibitor | 0.165 0.038 DBMET03690 0.096 0.093 DBMET03687 | DBMET03690 | |
| 0.008 | 0.272 | 0.042 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET03686 | DBMET03686 | |
| 0.03 | 0.295 | 0.06 | Phosphodiesterase 1C inhibitor | 0.06 0.049 DBMET03684 0.06 0.049 DBMET03685 | DBMET03685 | |
| 0.008 | 0.274 | 0.044 | Thromboxane A2 antagonist | 0.044 0.041 DBMET03687 | DBMET03687 | |
| 0.02 | 0.291 | 0.079 | Acetylcholine nicotinic agonist | 0.079 0.058 DBMET03684 0.079 0.058 DBMET03685 | DBMET03685 | |
| 0.07 | 0.341 | 0.154 | CF transmembrane conductance regulator agonist | 0.154 0.069 DBMET03684 0.154 0.069 DBMET03685 | DBMET03685 | |
| 0.069 | 0.34 | 0.138 | Pregnane X receptor agonist | 0.138 0.078 DBMET03684 0.138 0.078 DBMET03685 | DBMET03685 | |
| 0.002 | 0.275 | 0.014 | Angiotensin AT1B receptor antagonist | 0.014 0.01 DBMET03689 | DBMET03689 | |
| 0.01 | 0.284 | 0.079 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET03688 0.079 0.014 DBMET03687 0.058 0.02 DBMET03689 | DBMET03687 | |
| 0.061 | 0.336 | 0.144 | Sigma receptor agonist | 0.144 0.09 DBMET03684 0.144 0.09 DBMET03685 | DBMET03685 | |
| 0.016 | 0.293 | 0.044 | Dipeptidyl peptidase IV inhibitor | 0.042 0.036 DBMET03687 0.044 0.03 DBMET03689 | DBMET03689 | |
| 0.06 | 0.339 | 0.138 | Sphingosine 1-phosphate receptor 2 antagonist | 0.134 0.067 DBMET03684 0.121 0.094 DBMET03686 0.132 0.07 DBMET03688 0.134 0.067 DBMET03685 0.138 0.059 DBMET03687 0.126 0.083 DBMET03689 | DBMET03687 | |
| 0.016 | 0.296 | 0.14 | Glutamate (mGluR group III) agonist | 0.123 0.007 DBMET03686 0.14 0.005 DBMET03688 0.055 0.021 DBMET03687 0.042 0.031 DBMET03689 | DBMET03688 | |
| 0.024 | 0.307 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.043 DBMET03684 0.052 0.043 DBMET03685 | DBMET03685 | |
| 0.009 | 0.3 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 DBMET03690 0.033 0.028 DBMET03689 | DBMET03690 | |
| 0.031 | 0.325 | 0.101 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 DBMET03690 0.095 0.064 DBMET03687 | DBMET03690 | |
| 0.043 | 0.338 | 0.129 | Aldehyde dehydrogenase inhibitor | 0.129 0.063 DBMET03686 0.105 0.09 DBMET03688 | DBMET03686 | |
| 0.049 | 0.344 | 0.115 | Mannose-6-phosphate isomerase inhibitor | 0.115 0.109 DBMET03686 | DBMET03686 | |
| 0.016 | 0.313 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DBMET03687 | DBMET03687 | |
| 0.05 | 0.349 | 0.533 | Immunostimulant | 0.354 0.063 DBMET03686 0.385 0.054 DBMET03688 0.533 0.025 DBMET03690 0.29 0.081 DBMET03687 0.255 0.094 DBMET03689 | DBMET03690 | |
| 0.022 | 0.322 | 0.138 | Alcohol dehydrogenase inhibitor | 0.138 0.025 DBMET03686 0.114 0.039 DBMET03688 0.082 0.076 DBMET03690 0.12 0.035 DBMET03687 0.103 0.049 DBMET03689 | DBMET03686 | |
| 0.069 | 0.38 | 0.15 | ATPase inhibitor | 0.135 0.131 DBMET03684 0.135 0.131 DBMET03685 0.15 0.101 DBMET03687 | DBMET03687 | |
| 0.012 | 0.327 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | 0.055 0.038 DBMET03690 | DBMET03690 | |
| 0.005 | 0.324 | 0.032 | AMPA 3 receptor antagonist | 0.032 0.019 DBMET03690 | DBMET03690 | |
| 0.014 | 0.334 | 0.058 | Sphingosine 1-phosphate receptor 4 agonist | 0.058 0.057 DBMET03688 | DBMET03688 | |
| 0.004 | 0.325 | 0.06 | Kainate receptor antagonist | 0.045 0.025 DBMET03686 0.06 0.016 DBMET03688 0.047 0.023 DBMET03690 0.058 0.017 DBMET03687 0.045 0.025 DBMET03689 | DBMET03688 | |
| 0.049 | 0.374 | 0.15 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.09 DBMET03684 0.112 0.09 DBMET03685 0.15 0.033 DBMET03687 0.135 0.049 DBMET03689 | DBMET03687 | |
| 0.039 | 0.365 | 0.16 | Acetylcholine M1 receptor antagonist | 0.126 0.1 DBMET03684 0.126 0.1 DBMET03685 0.16 0.065 DBMET03687 0.135 0.09 DBMET03689 | DBMET03687 | |
| 0.017 | 0.345 | 0.075 | Acetylcholine agonist | 0.075 0.074 DBMET03684 0.075 0.074 DBMET03685 | DBMET03685 | |
| 0.006 | 0.336 | 0.036 | Caspase 2 inhibitor | 0.036 0.018 DBMET03690 | DBMET03690 | |
| 0.057 | 0.388 | 0.107 | DNA repair enzyme inhibitor | 0.107 0.104 DBMET03684 0.107 0.104 DBMET03685 | DBMET03685 | |
| 0.002 | 0.337 | 0.043 | AMPA 1 receptor antagonist | 0.043 0.013 DBMET03690 | DBMET03690 | |
| 0.088 | 0.425 | 0.305 | Vasodilator, coronary | 0.209 0.174 DBMET03684 0.209 0.174 DBMET03685 0.305 0.083 DBMET03687 0.276 0.109 DBMET03689 | DBMET03687 | |
| 0.005 | 0.345 | 0.037 | Carnitine palmitoyltransferase 1A inhibitor | 0.037 0.011 DBMET03687 0.032 0.015 DBMET03689 | DBMET03687 | |
| 0.003 | 0.344 | 0.031 | Aminopeptidase P inhibitor | 0.024 0.015 DBMET03686 0.023 0.017 DBMET03688 0.031 0.009 DBMET03690 | DBMET03690 | |
| 0.005 | 0.353 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.015 DBMET03690 | DBMET03690 | |
| 0.008 | 0.357 | 0.096 | Neutrophil collagenase inhibitor | 0.096 0.024 DBMET03690 0.056 0.055 DBMET03687 | DBMET03690 | |
| 0.035 | 0.388 | 0.085 | Lanosterol 14 alpha demethylase inhibitor | 0.085 0.082 DBMET03684 0.085 0.082 DBMET03685 | DBMET03685 | |
| 0.005 | 0.367 | 0.026 | LFA antagonist | 0.026 0.022 DBMET03687 | DBMET03687 | |
| 0.005 | 0.367 | 0.051 | Angiotensin AT1 receptor antagonist | 0.046 0.023 DBMET03687 0.051 0.016 DBMET03689 | DBMET03689 | |
| 0.005 | 0.37 | 0.053 | Glutamate (mGluR1) antagonist | 0.053 0.045 DBMET03687 | DBMET03687 | |
| 0.007 | 0.374 | 0.04 | Angiotensin II receptor antagonist | 0.036 0.021 DBMET03687 0.04 0.014 DBMET03689 | DBMET03689 | |
| 0.055 | 0.43 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET03687 0.151 0.15 DBMET03689 | DBMET03687 | |
| 0.027 | 0.404 | 0.105 | Acetylcholine antagonist | 0.105 0.086 DBMET03687 | DBMET03687 | |
| 0.027 | 0.405 | 0.108 | Cholinergic antagonist | 0.108 0.086 DBMET03687 | DBMET03687 | |
| 0.019 | 0.407 | 0.077 | Calcium channel L-type blocker | 0.077 0.043 DBMET03687 0.064 0.062 DBMET03689 | DBMET03687 | |
| 0.073 | 0.465 | 0.369 | Vasodilator, peripheral | 0.196 0.181 DBMET03682 0.227 0.147 DBMET03684 0.227 0.147 DBMET03685 0.369 0.066 DBMET03687 0.31 0.092 DBMET03689 | DBMET03687 | |
| 0.025 | 0.417 | 0.121 | Caspase 3 inhibitor | 0.121 0.058 DBMET03690 0.098 0.095 DBMET03687 | DBMET03690 | |
| 0.033 | 0.432 | 0.102 | Interleukin 8 antagonist | 0.102 0.092 DBMET03688 | DBMET03688 | |
| 0.009 | 0.409 | 0.074 | Matrix metalloproteinase inhibitor | 0.074 0.041 DBMET03690 0.058 0.056 DBMET03689 | DBMET03690 | |
| 0.012 | 0.411 | 0.03 | DNA topoisomerase IV inhibitor | 0.03 0.022 DBMET03687 | DBMET03687 | |
| 0.013 | 0.415 | 0.165 | Inducible nitric-oxide synthase inhibitor | 0.157 0.015 DBMET03686 0.165 0.013 DBMET03688 0.078 0.066 DBMET03690 0.076 0.068 DBMET03687 0.089 0.048 DBMET03689 | DBMET03688 | |
| 0.014 | 0.421 | 0.098 | Glutamate (mGluR8) antagonist | 0.044 0.013 DBMET03682 0.065 0.004 DBMET03686 0.085 0.003 DBMET03688 0.052 0.008 DBMET03690 0.098 0.003 DBMET03687 0.09 0.003 DBMET03689 | DBMET03687 | |
| 0.037 | 0.449 | 0.14 | Neuropeptide Y1 antagonist | 0.126 0.108 DBMET03687 0.14 0.081 DBMET03689 | DBMET03689 | |
| 0.012 | 0.429 | 0.092 | Metalloproteinase-2 inhibitor | 0.092 0.043 DBMET03690 0.073 0.061 DBMET03689 | DBMET03690 | |
| 0.007 | 0.432 | 0.053 | Dihydroorotate dehydrogenase inhibitor | 0.053 0.034 DBMET03687 | DBMET03687 | |
| 0.023 | 0.456 | 0.12 | Nav1.6 sodium channel blocker | 0.12 0.096 DBMET03684 0.12 0.096 DBMET03685 | DBMET03685 | |
| 0.026 | 0.462 | 0.176 | Phospholipase A2 inhibitor | 0.176 0.056 DBMET03690 0.129 0.102 DBMET03687 | DBMET03690 | |
| 0.023 | 0.461 | 0.07 | Cathepsin E inhibitor | 0.07 0.029 DBMET03690 0.061 0.039 DBMET03687 0.056 0.046 DBMET03689 | DBMET03690 | |
| 0.054 | 0.499 | 0.34 | Antithrombotic | 0.259 0.119 DBMET03686 0.235 0.139 DBMET03688 0.313 0.08 DBMET03690 0.34 0.068 DBMET03687 0.3 0.088 DBMET03689 | DBMET03687 | |
| 0.008 | 0.454 | 0.043 | Dopamine transporter inhibitor | 0.043 0.04 DBMET03684 0.043 0.04 DBMET03685 | DBMET03685 | |
| 0.017 | 0.464 | 0.164 | Nitric-oxide synthase inhibitor | 0.154 0.021 DBMET03686 0.164 0.018 DBMET03688 0.1 0.06 DBMET03690 0.089 0.079 DBMET03687 0.103 0.055 DBMET03689 | DBMET03688 | |
| 0.051 | 0.509 | 0.186 | Neuropeptide Y2 antagonist | 0.175 0.172 DBMET03684 0.186 0.146 DBMET03690 0.175 0.172 DBMET03685 | DBMET03690 | |
| 0.036 | 0.495 | 0.204 | Thiol protease inhibitor | 0.129 0.098 DBMET03688 0.204 0.038 DBMET03690 0.141 0.079 DBMET03687 0.126 0.104 DBMET03689 | DBMET03690 | |
| 0.009 | 0.47 | 0.066 | Metalloproteinase-9 inhibitor | 0.066 0.064 DBMET03690 | DBMET03690 | |
| 0.027 | 0.49 | 0.214 | Insulin sensitizer | 0.203 0.07 DBMET03686 0.209 0.065 DBMET03688 0.214 0.06 DBMET03690 0.182 0.093 DBMET03687 0.161 0.118 DBMET03689 | DBMET03690 | |
| 0.019 | 0.483 | 0.127 | Cytidine deaminase inhibitor | 0.127 0.094 DBMET03687 | DBMET03687 | |
| 0.031 | 0.498 | 0.258 | DNA methyltransferase I inhibitor | 0.208 0.065 DBMET03686 0.258 0.044 DBMET03688 0.19 0.074 DBMET03687 0.152 0.101 DBMET03689 | DBMET03688 | |
| 0.027 | 0.495 | 0.274 | Spasmolytic | 0.224 0.103 DBMET03687 0.274 0.081 DBMET03689 | DBMET03689 | |
| 0.03 | 0.501 | 0.071 | Prolactin release inhibitor | 0.06 0.051 DBMET03684 0.06 0.051 DBMET03685 0.071 0.021 DBMET03687 0.067 0.029 DBMET03689 | DBMET03687 | |
| 0.038 | 0.515 | 0.138 | Hexokinase inhibitor | 0.138 0.093 DBMET03687 | DBMET03687 | |
| 0.019 | 0.503 | 0.203 | Somatostatin 1 agonist | 0.093 0.039 DBMET03686 0.088 0.043 DBMET03688 0.115 0.026 DBMET03690 0.203 0.007 DBMET03687 0.191 0.007 DBMET03689 | DBMET03687 | |
| 0.015 | 0.506 | 0.08 | Bombesin 1 receptor agonist | 0.066 0.034 DBMET03688 0.08 0.025 DBMET03690 | DBMET03690 | |
| 0.006 | 0.499 | 0.186 | Angiotensin-converting enzyme inhibitor | 0.077 0.015 DBMET03686 0.08 0.014 DBMET03688 0.093 0.01 DBMET03690 0.181 0.004 DBMET03687 0.186 0.004 DBMET03689 | DBMET03689 | |
| 0.027 | 0.525 | 0.094 | Phosphodiesterase 7B inhibitor | 0.094 0.064 DBMET03684 0.094 0.064 DBMET03685 | DBMET03685 | |
| 0.007 | 0.51 | 0.059 | Collagenase 3 inhibitor | 0.059 0.042 DBMET03689 | DBMET03689 | |
| 0.03 | 0.538 | 0.264 | DNA methylase inhibitor | 0.225 0.063 DBMET03686 0.264 0.041 DBMET03688 0.191 0.085 DBMET03687 0.152 0.116 DBMET03689 | DBMET03688 | |
| 0.013 | 0.529 | 0.291 | Diuretic | 0.124 0.1 DBMET03686 0.128 0.097 DBMET03690 0.244 0.032 DBMET03687 0.291 0.024 DBMET03689 | DBMET03689 | |
| 0.08 | 0.599 | 0.314 | Peptidyltransferase inhibitor | 0.184 0.122 DBMET03682 0.258 0.045 DBMET03686 0.252 0.05 DBMET03688 0.314 0.02 DBMET03690 0.221 0.075 DBMET03687 0.203 0.096 DBMET03689 | DBMET03690 | |
| 0.024 | 0.554 | 0.183 | Calpain inhibitor | 0.183 0.131 DBMET03690 0.167 0.153 DBMET03689 | DBMET03690 | |
| 0.005 | 0.545 | 0.107 | NMDA receptor antagonist | 0.107 0.043 DBMET03687 0.08 0.065 DBMET03689 | DBMET03687 | |
| 0.021 | 0.565 | 0.117 | Antibacterial (Helicobacter pylori) | 0.117 0.086 DBMET03686 0.115 0.09 DBMET03687 | DBMET03686 | |
| 0.027 | 0.572 | 0.182 | Non-steroidal antiinflammatory agent | 0.147 0.119 DBMET03687 0.182 0.085 DBMET03689 | DBMET03689 | |
| 0.005 | 0.558 | 0.1 | Glutamate receptor agonist | 0.1 0.037 DBMET03686 0.099 0.038 DBMET03688 0.096 0.04 DBMET03687 0.07 0.063 DBMET03689 | DBMET03686 | |
| 0.03 | 0.592 | 0.235 | Transcription factor STAT3 inhibitor | 0.192 0.145 DBMET03684 0.184 0.158 DBMET03688 0.185 0.156 DBMET03690 0.235 0.096 DBMET03687 0.199 0.135 DBMET03689 | DBMET03687 | |
| 0.003 | 0.574 | 0.02 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET03690 0.02 0.009 DBMET03687 0.018 0.012 DBMET03689 | DBMET03687 | |
| 0.004 | 0.581 | 0.042 | Bradykinin B2 receptor agonist | 0.027 0.021 DBMET03686 0.025 0.024 DBMET03688 0.042 0.01 DBMET03690 | DBMET03690 | |
| 0.004 | 0.595 | 0.033 | Prostaglandin D2 agonist | 0.033 0.019 DBMET03687 0.028 0.025 DBMET03689 | DBMET03687 | |
| 0.021 | 0.614 | 0.069 | Caspase 9 inhibitor | 0.069 0.033 DBMET03690 | DBMET03690 | |
| 0.009 | 0.634 | 0.049 | Phosphodiesterase 7A inhibitor | 0.049 0.043 DBMET03684 0.049 0.043 DBMET03685 | DBMET03685 | |
| 0.009 | 0.643 | 0.078 | Neurotensin receptor antagonist | 0.045 0.031 DBMET03686 0.042 0.034 DBMET03688 0.078 0.019 DBMET03690 | DBMET03690 | |
| 0.002 | 0.661 | 0.02 | Retinoid X beta receptor agonist | 0.02 0.016 DBMET03687 | DBMET03687 | |
| 0.017 | 0.679 | 0.135 | Hemostatic | 0.127 0.101 DBMET03690 0.135 0.089 DBMET03687 | DBMET03687 | |
| 0.013 | 0.678 | 0.047 | Factor III inhibitor | 0.047 0.042 DBMET03687 | DBMET03687 | |
| 0.004 | 0.67 | 0.025 | Retinoic acid gamma receptor agonist | 0.025 0.011 DBMET03687 0.023 0.015 DBMET03689 | DBMET03687 | |
| 0.057 | 0.723 | 0.154 | MAP kinase kinase 5 inhibitor | 0.154 0.136 DBMET03684 0.154 0.136 DBMET03685 | DBMET03685 | |
| 0.017 | 0.689 | 0.144 | Antipruritic | 0.144 0.102 DBMET03687 | DBMET03687 | |
| 0.004 | 0.69 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 DBMET03687 0.032 0.03 DBMET03689 | DBMET03687 | |
| 0.002 | 0.688 | 0.03 | Neutral endopeptidase inhibitor | 0.018 0.017 DBMET03686 0.03 0.012 DBMET03690 0.021 0.015 DBMET03689 | DBMET03690 | |
| 0.012 | 0.702 | 0.081 | Opioid kappa receptor antagonist | 0.081 0.056 DBMET03687 | DBMET03687 | |
| 0.023 | 0.715 | 0.208 | Transcription factor STAT inhibitor | 0.208 0.126 DBMET03687 | DBMET03687 | |
| 0.003 | 0.702 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.021 DBMET03687 | DBMET03687 | |
| 0.004 | 0.705 | 0.087 | Opioid mu receptor antagonist | 0.065 0.05 DBMET03686 0.087 0.037 DBMET03688 0.084 0.038 DBMET03690 0.068 0.047 DBMET03687 | DBMET03688 | |
| 0.005 | 0.711 | 0.028 | Tryptophan hydroxylase 1 inhibitor | 0.028 0.004 DBMET03686 0.025 0.004 DBMET03688 0.018 0.009 DBMET03690 0.022 0.005 DBMET03687 0.02 0.006 DBMET03689 | DBMET03686 | |
| 0.002 | 0.71 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET03687 | DBMET03687 | |
| 0.01 | 0.72 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 DBMET03688 | DBMET03688 | |
| 0.024 | 0.737 | 0.314 | Hematopoietic | 0.101 0.034 DBMET03686 0.127 0.02 DBMET03688 0.314 0.005 DBMET03690 0.093 0.044 DBMET03687 0.084 0.061 DBMET03689 | DBMET03690 | |
| 0.001 | 0.715 | 0.017 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.017 0.008 DBMET03690 | DBMET03690 | |
| 0.016 | 0.754 | 0.151 | Nav1.4 sodium channel blocker | 0.151 0.033 DBMET03686 0.141 0.038 DBMET03688 0.147 0.035 DBMET03690 0.144 0.036 DBMET03687 0.131 0.044 DBMET03689 | DBMET03686 | |
| 0.006 | 0.753 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 DBMET03687 0.054 0.018 DBMET03689 | DBMET03687 | |
| 0.011 | 0.762 | 0.41 | Angiogenesis stimulant | 0.32 0.042 DBMET03686 0.339 0.036 DBMET03688 0.41 0.02 DBMET03690 0.252 0.069 DBMET03687 0.217 0.086 DBMET03689 | DBMET03690 | |
| 0.014 | 0.766 | 0.047 | Parathyroid hormone antagonist | 0.047 0.027 DBMET03688 | DBMET03688 | |
| 0.069 | 0.822 | 0.352 | Calcium channel L-type activator | 0.352 0.116 DBMET03687 0.309 0.15 DBMET03689 | DBMET03687 | |
| 0.034 | 0.797 | 0.442 | Sodium/bile acid cotransporter inhibitor | 0.277 0.101 DBMET03682 0.22 0.162 DBMET03686 0.221 0.161 DBMET03688 0.442 0.008 DBMET03690 0.321 0.061 DBMET03687 0.298 0.081 DBMET03689 | DBMET03690 | |
| 0.004 | 0.768 | 0.047 | Opioid mu receptor agonist | 0.047 0.032 DBMET03690 | DBMET03690 | |
| 0.003 | 0.771 | 0.022 | Retinoic acid receptor agonist | 0.022 0.017 DBMET03687 | DBMET03687 | |
| 0.01 | 0.778 | 0.122 | Factor XII inhibitor | 0.098 0.039 DBMET03686 0.102 0.035 DBMET03688 0.122 0.023 DBMET03690 0.09 0.049 DBMET03687 0.081 0.063 DBMET03689 | DBMET03690 | |
| 0.004 | 0.778 | 0.086 | Opioid delta receptor antagonist | 0.055 0.05 DBMET03686 0.086 0.034 DBMET03688 0.081 0.036 DBMET03690 0.058 0.048 DBMET03687 | DBMET03688 | |
| 0.012 | 0.786 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.016 DBMET03686 0.041 0.02 DBMET03688 0.037 0.031 DBMET03690 | DBMET03686 | |
| 0.003 | 0.785 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.011 DBMET03687 0.019 0.015 DBMET03689 | DBMET03687 | |
| 0.006 | 0.789 | 0.055 | Growth hormone release inhibitor | 0.055 0.018 DBMET03690 | DBMET03690 | |
| 0.032 | 0.816 | 0.383 | Growth hormone agonist | 0.311 0.03 DBMET03686 0.383 0.018 DBMET03688 0.383 0.018 DBMET03690 | DBMET03690 | |
| 0.01 | 0.798 | 0.586 | Antibacterial | 0.267 0.161 DBMET03686 0.279 0.151 DBMET03688 0.223 0.203 DBMET03690 0.586 0.021 DBMET03687 0.572 0.024 DBMET03689 | DBMET03687 | |
| 0.007 | 0.798 | 0.102 | Opioid antagonist | 0.083 0.065 DBMET03686 0.102 0.046 DBMET03688 0.102 0.046 DBMET03690 0.09 0.056 DBMET03687 | DBMET03690 | |
| 0.002 | 0.803 | 0.019 | Retinoic acid alpha receptor antagonist | 0.019 0.016 DBMET03687 | DBMET03687 | |
| 0.008 | 0.809 | 0.053 | Neurokinin 2 agonist | 0.053 0.017 DBMET03688 0.051 0.018 DBMET03690 | DBMET03688 | |
| 0.01 | 0.823 | 0.088 | Chymotrypsin inhibitor | 0.074 0.064 DBMET03686 0.088 0.045 DBMET03690 | DBMET03690 | |
| 0.005 | 0.823 | 0.076 | Nitric oxide donor | 0.076 0.026 DBMET03690 | DBMET03690 | |
| 0.001 | 0.821 | 0.015 | Carbonic anhydrase IV stimulant | 0.015 0.011 DBMET03690 | DBMET03690 | |
| 0.002 | 0.823 | 0.032 | Integrin beta7 antagonist | 0.032 0.009 DBMET03686 0.028 0.01 DBMET03688 | DBMET03686 | |
| 0.006 | 0.833 | 0.1 | Erythropoietin receptor agonist | 0.038 0.03 DBMET03686 0.1 0.01 DBMET03690 | DBMET03690 | |
| 0.008 | 0.841 | 0.044 | Carnitine palmitoyltransferase 1B inhibitor | 0.044 0.04 DBMET03687 | DBMET03687 | |
| 0.013 | 0.847 | 0.065 | DNA helicase inhibitor | 0.055 0.037 DBMET03682 0.065 0.022 DBMET03686 0.057 0.033 DBMET03688 0.059 0.029 DBMET03687 0.054 0.039 DBMET03689 | DBMET03686 | |
| 0.01 | 0.857 | 0.078 | Vanilloid agonist | 0.078 0.075 DBMET03690 | DBMET03690 | |
| 0.004 | 0.857 | 0.05 | Retinoic acid alpha receptor agonist | 0.05 0.015 DBMET03687 0.044 0.019 DBMET03689 | DBMET03687 | |
| 0.003 | 0.857 | 0.052 | AMPA receptor agonist | 0.049 0.009 DBMET03686 0.052 0.008 DBMET03688 0.04 0.017 DBMET03687 0.036 0.024 DBMET03689 | DBMET03688 | |
| 0.006 | 0.866 | 0.054 | Human rhinovirus A protease inhibitor | 0.054 0.039 DBMET03690 | DBMET03690 | |
| 0.003 | 0.866 | 0.031 | Somatostatin 3 antagonist | 0.02 0.014 DBMET03687 0.031 0.009 DBMET03689 | DBMET03689 | |
| 0.002 | 0.868 | 0.07 | VLA-4 antagonist | 0.07 0.009 DBMET03686 0.058 0.011 DBMET03688 0.023 0.02 DBMET03690 0.056 0.012 DBMET03687 0.033 0.016 DBMET03689 | DBMET03686 | |
| 0.003 | 0.877 | 0.084 | NMDA 2D receptor antagonist | 0.084 0.004 DBMET03687 0.072 0.005 DBMET03689 | DBMET03687 | |
| 0.005 | 0.884 | 0.051 | Bombesin antagonist | 0.051 0.029 DBMET03690 | DBMET03690 | |
| 0.004 | 0.884 | 0.071 | Analgesic, opioid | 0.068 0.065 DBMET03688 0.071 0.06 DBMET03690 | DBMET03690 | |
| 0.004 | 0.892 | 0.044 | VCAM-1 antagonist | 0.044 0.016 DBMET03686 0.041 0.022 DBMET03688 0.039 0.029 DBMET03690 | DBMET03686 | |
| 0.004 | 0.892 | 0.044 | VCAM antagonist | 0.044 0.016 DBMET03686 0.041 0.022 DBMET03688 0.039 0.029 DBMET03690 | DBMET03686 | |
| 0.007 | 0.897 | 0.052 | Cathepsin F inhibitor | 0.052 0.01 DBMET03690 | DBMET03690 | |
| 0.011 | 0.904 | 0.082 | Adenine nucleotide translocase inhibitor | 0.052 0.049 DBMET03686 0.063 0.023 DBMET03688 0.082 0.008 DBMET03690 0.081 0.009 DBMET03687 0.076 0.011 DBMET03689 | DBMET03690 | |
| 0.002 | 0.898 | 0.099 | Leukotriene A4 hydrolase inhibitor | 0.051 0.02 DBMET03686 0.099 0.006 DBMET03688 0.092 0.007 DBMET03690 0.057 0.017 DBMET03687 0.036 0.028 DBMET03689 | DBMET03688 | |
| 0.003 | 0.906 | 0.066 | Somatostatin 1 antagonist | 0.066 0.013 DBMET03687 0.059 0.015 DBMET03689 | DBMET03687 | |
| 0.006 | 0.915 | 0.057 | Cholecystokinin B agonist | 0.038 0.026 DBMET03688 0.057 0.013 DBMET03690 0.042 0.021 DBMET03689 | DBMET03690 | |
| 0.016 | 0.931 | 0.106 | Transcription factor NF kappa B stimulant | 0.106 0.034 DBMET03690 | DBMET03690 | |
| 0.022 | 0.942 | 0.163 | Factor V inhibitor | 0.108 0.053 DBMET03686 0.108 0.054 DBMET03688 0.163 0.013 DBMET03690 | DBMET03690 | |
| 0.009 | 0.931 | 0.068 | Carbonic anhydrase II stimulant | 0.049 0.042 DBMET03686 0.047 0.046 DBMET03688 0.068 0.016 DBMET03690 | DBMET03690 | |
| 0.004 | 0.929 | 0.067 | Endothelin-converting enzyme inhibitor | 0.04 0.038 DBMET03686 0.067 0.022 DBMET03690 | DBMET03690 | |
| 0.002 | 0.93 | 0.107 | GP IIb/IIIa receptor antagonist | 0.052 0.031 DBMET03686 0.05 0.032 DBMET03688 0.107 0.016 DBMET03690 | DBMET03690 | |
| 0.003 | 0.934 | 0.061 | Carbonic anhydrase I stimulant | 0.061 0.011 DBMET03690 | DBMET03690 | |
| 0.003 | 0.941 | 0.06 | Integrin alpha5beta1 antagonist | 0.043 0.025 DBMET03686 0.04 0.029 DBMET03688 0.06 0.012 DBMET03690 0.037 0.034 DBMET03687 | DBMET03690 | |
| 0.004 | 0.948 | 0.181 | Neurotrophic factor | 0.181 0.037 DBMET03687 0.146 0.062 DBMET03689 | DBMET03687 | |
| 0.01 | 0.956 | 0.09 | T cell inhibitor | 0.09 0.039 DBMET03687 0.081 0.061 DBMET03689 | DBMET03687 | |
| 0.017 | 0.964 | 0.144 | Folate antagonist | 0.127 0.034 DBMET03686 0.122 0.037 DBMET03688 0.144 0.024 DBMET03690 | DBMET03690 | |
| 0.006 | 0.955 | 0.03 | Vasopressin 1A agonist | 0.03 0.017 DBMET03689 | DBMET03689 | |
| 0.003 | 0.955 | 0.067 | Aminopeptidase N inhibitor | 0.054 0.028 DBMET03686 0.058 0.026 DBMET03688 0.067 0.021 DBMET03690 | DBMET03690 | |
| 0.002 | 0.953 | 0.029 | Integrin alpha4beta7 antagonist | 0.029 0.009 DBMET03686 0.025 0.011 DBMET03688 | DBMET03686 | |
| 0.002 | 0.955 | 0.073 | Complement C3a chemotactic receptor antagonist | 0.065 0.02 DBMET03686 0.06 0.022 DBMET03688 0.073 0.017 DBMET03690 | DBMET03690 | |
| 0.002 | 0.956 | 0.032 | Renin inhibitor | 0.032 0.029 DBMET03690 | DBMET03690 | |
| 0.003 | 0.959 | 0.039 | Vasopressin 1 agonist | 0.039 0.004 DBMET03689 | DBMET03689 | |
| 0.002 | 0.96 | 0.047 | Integrin alpha4 antagonist | 0.044 0.012 DBMET03686 0.035 0.014 DBMET03688 0.025 0.018 DBMET03687 0.047 0.012 DBMET03689 | DBMET03689 | |
| 0.002 | 0.96 | 0.029 | Cholecystokinin B antagonist | 0.029 0.023 DBMET03690 | DBMET03690 | |
| 0.002 | 0.961 | 0.05 | Somatostatin 2 antagonist | 0.05 0.015 DBMET03689 | DBMET03689 | |
| 0.008 | 0.971 | 0.264 | Hepatoprotectant | 0.223 0.053 DBMET03686 0.213 0.057 DBMET03688 0.264 0.04 DBMET03690 0.194 0.069 DBMET03687 0.172 0.087 DBMET03689 | DBMET03690 | |
| 0.003 | 0.967 | 0.087 | Aminopeptidase microsomal inhibitor | 0.074 0.028 DBMET03686 0.079 0.025 DBMET03688 0.087 0.022 DBMET03690 | DBMET03690 | |
| 0.002 | 0.968 | 0.047 | Purinergic P2X7 antagonist | 0.047 0.016 DBMET03689 | DBMET03689 | |
| 0.002 | 0.969 | 0.035 | Somatostatin 4 antagonist | 0.023 0.017 DBMET03687 0.035 0.01 DBMET03689 | DBMET03689 | |
| 0.003 | 0.969 | 0.122 | Neuraminidase inhibitor | 0.122 0.009 DBMET03687 0.102 0.014 DBMET03689 | DBMET03687 | |
| 0.002 | 0.968 | 0.029 | Kainate receptor 3 antagonist | 0.029 0.005 DBMET03688 | DBMET03688 | |
| 0.004 | 0.974 | 0.108 | Sirtuin 1 inhibitor | 0.075 0.039 DBMET03686 0.108 0.019 DBMET03688 0.105 0.02 DBMET03690 | DBMET03688 | |
| 0.003 | 0.973 | 0.096 | Protein kinase C iota inhibitor | 0.096 0.02 DBMET03686 0.085 0.024 DBMET03688 | DBMET03686 | |
| 0.004 | 0.977 | 0.184 | Amyloid beta precursor protein antagonist | 0.184 0.069 DBMET03687 0.142 0.11 DBMET03689 | DBMET03687 | |
| 0.003 | 0.976 | 0.091 | Neuraminidase (influenza) inhibitor | 0.091 0.019 DBMET03687 0.075 0.03 DBMET03689 | DBMET03687 | |
| 0.006 | 0.98 | 0.231 | Histone deacetylase SIRT1 inhibitor | 0.134 0.076 DBMET03686 0.188 0.035 DBMET03688 0.231 0.021 DBMET03690 | DBMET03690 | |
| 0.001 | 0.975 | 0.03 | Kainate receptor 5 antagonist | 0.03 0.009 DBMET03688 0.021 0.014 DBMET03687 | DBMET03688 | |
| 0.002 | 0.976 | 0.029 | Kainate receptor 4 antagonist | 0.029 0.014 DBMET03688 | DBMET03688 | |
| 0.002 | 0.977 | 0.087 | Somatostatin 5 antagonist | 0.062 0.01 DBMET03687 0.087 0.007 DBMET03689 | DBMET03689 | |
| 0.004 | 0.979 | 0.075 | Neuropeptide agonist | 0.075 0.033 DBMET03690 | DBMET03690 | |
| 0.002 | 0.978 | 0.056 | Oxytocin antagonist | 0.056 0.016 DBMET03689 | DBMET03689 | |
| 0.002 | 0.978 | 0.051 | Collagenase inhibitor | 0.051 0.031 DBMET03690 | DBMET03690 | |
| 0.006 | 0.985 | 0.053 | Kallikrein 1 inhibitor | 0.053 0.046 DBMET03690 | DBMET03690 | |
| 0.002 | 0.981 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 DBMET03690 | DBMET03690 | |
| 0.003 | 0.982 | 0.121 | M17 leucyl aminopeptidase inhibitor | 0.121 0.077 DBMET03687 | DBMET03687 | |
| 0.003 | 0.984 | 0.085 | Cathepsin B inhibitor | 0.085 0.022 DBMET03690 | DBMET03690 | |
| 0.005 | 0.988 | 0.338 | Apoptosis antagonist | 0.196 0.184 DBMET03682 0.338 0.062 DBMET03690 | DBMET03690 | |
| 0.001 | 0.984 | 0.145 | Vasopressin 2 agonist | 0.145 0.003 DBMET03689 | DBMET03689 | |
| 0.004 | 0.987 | 0.133 | Protease inhibitor | 0.133 0.039 DBMET03690 | DBMET03690 | |
| 0.002 | 0.987 | 0.143 | Antidiuretic hormone agonist | 0.143 0.004 DBMET03689 | DBMET03689 | |
| 0.002 | 0.987 | 0.061 | Integrin antagonist | 0.059 0.025 DBMET03686 0.051 0.027 DBMET03688 0.061 0.024 DBMET03690 0.042 0.03 DBMET03689 | DBMET03690 | |
| 0.002 | 0.987 | 0.258 | Kinesin antagonist | 0.258 0.004 DBMET03686 0.038 0.024 DBMET03688 | DBMET03686 | |
| 0.002 | 0.987 | 0.258 | Kinesin-like protein 1 inhibitor | 0.258 0.004 DBMET03686 0.038 0.024 DBMET03688 | DBMET03686 | |
| 0.002 | 0.988 | 0.105 | Glucagon-like peptide 1 agonist | 0.069 0.042 DBMET03686 0.085 0.031 DBMET03688 0.105 0.019 DBMET03690 0.058 0.05 DBMET03689 | DBMET03690 | |
| 0.002 | 0.988 | 0.056 | Purinergic P2X antagonist | 0.056 0.026 DBMET03689 | DBMET03689 | |
| 0.004 | 0.991 | 0.171 | Free radical scavenger | 0.157 0.137 DBMET03686 0.171 0.122 DBMET03690 | DBMET03690 | |
| 0.003 | 0.991 | 0.06 | Trypsin inhibitor | 0.06 0.046 DBMET03690 | DBMET03690 | |
| 0.003 | 0.991 | 0.146 | Histone deacetylase class III inhibitor | 0.146 0.047 DBMET03690 | DBMET03690 | |
| 0.002 | 0.99 | 0.041 | AMPA 2 receptor antagonist | 0.041 0.014 DBMET03688 0.033 0.018 DBMET03690 0.034 0.017 DBMET03687 | DBMET03688 | |
| 0.004 | 0.991 | 0.241 | Chelator | 0.099 0.079 DBMET03686 0.241 0.018 DBMET03690 0.128 0.047 DBMET03687 0.104 0.072 DBMET03689 | DBMET03690 | |
| 0.002 | 0.991 | 0.115 | Selectin antagonist | 0.115 0.023 DBMET03690 | DBMET03690 | |
| 0.004 | 0.993 | 0.387 | Immunosuppressant | 0.217 0.179 DBMET03686 0.294 0.119 DBMET03688 0.285 0.124 DBMET03690 0.387 0.069 DBMET03687 0.312 0.108 DBMET03689 | DBMET03687 | |
| 0.004 | 0.993 | 0.232 | Antioxidant | 0.168 0.145 DBMET03686 0.187 0.125 DBMET03690 0.232 0.094 DBMET03687 0.186 0.126 DBMET03689 | DBMET03687 | |
| 0.001 | 0.991 | 0.023 | Angiotensin AT1A receptor antagonist | 0.023 0.012 DBMET03689 | DBMET03689 | |
| 0.002 | 0.992 | 0.029 | Prostacyclin antagonist | 0.029 0.027 DBMET03686 | DBMET03686 | |
| 0.004 | 0.994 | 0.292 | Immunomodulator | 0.292 0.087 DBMET03690 | DBMET03690 | |
| 0.002 | 0.993 | 0.084 | Glutamate (mGluR) agonist | 0.084 0.029 DBMET03688 | DBMET03688 | |
| 0.002 | 0.992 | 0.046 | Protocollagen prolyl hydroxylase inhibitor | 0.046 0.006 DBMET03690 | DBMET03690 | |
| 0.004 | 0.995 | 0.053 | Glucagon-like peptide 1 receptor antagonist | 0.053 0.011 DBMET03689 | DBMET03689 | |
| 0.003 | 0.994 | 0.05 | Cathepsin D inhibitor | 0.05 0.042 DBMET03690 | DBMET03690 | |
| 0.004 | 0.995 | 0.15 | Bone formation stimulant | 0.15 0.059 DBMET03690 | DBMET03690 | |
| 0.003 | 0.995 | 0.378 | Thrombolytic | 0.271 0.029 DBMET03686 0.296 0.024 DBMET03688 0.378 0.013 DBMET03690 0.176 0.064 DBMET03687 0.139 0.09 DBMET03689 | DBMET03690 | |
| 0.004 | 0.995 | 0.144 | Insulin secretagoues | 0.125 0.103 DBMET03688 0.144 0.08 DBMET03687 | DBMET03687 | |
| 0.003 | 0.995 | 0.119 | Cell adhesion inhibitor | 0.115 0.069 DBMET03686 0.115 0.069 DBMET03688 0.119 0.066 DBMET03690 | DBMET03690 | |
| 0.003 | 0.995 | 0.077 | Thrombin inhibitor | 0.077 0.045 DBMET03690 | DBMET03690 | |
| 0.003 | 0.995 | 0.205 | Aminoacyl-tRNA synthetase inhibitor | 0.138 0.023 DBMET03686 0.205 0.01 DBMET03688 0.133 0.024 DBMET03690 | DBMET03688 | |
| 0.003 | 0.995 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.068 DBMET03690 | DBMET03690 | |
| 0.002 | 0.995 | 0.146 | Protein-tyrosine phosphatase 1B inhibitor | 0.128 0.057 DBMET03682 0.146 0.047 DBMET03687 0.113 0.068 DBMET03689 | DBMET03687 | |
| 0.003 | 0.996 | 0.268 | Anticoagulant | 0.129 0.101 DBMET03686 0.151 0.08 DBMET03688 0.268 0.034 DBMET03690 | DBMET03690 | |
| 0.003 | 0.996 | 0.163 | Hypoglycemic | 0.163 0.158 DBMET03687 | DBMET03687 | |
| 0.003 | 0.996 | 0.24 | Protein-tyrosine phosphatase inhibitor | 0.149 0.079 DBMET03682 0.24 0.034 DBMET03687 0.188 0.052 DBMET03689 | DBMET03687 | |
| 0.003 | 0.996 | 0.316 | Platelet antagonist | 0.316 0.048 DBMET03682 0.208 0.095 DBMET03686 0.211 0.094 DBMET03688 0.304 0.051 DBMET03690 | DBMET03682 | |
| 0.002 | 0.995 | 0.044 | Macrophage elastase inhibitor | 0.044 0.029 DBMET03690 | DBMET03690 | |
| 0.002 | 0.995 | 0.085 | Purinergic P2 antagonist | 0.085 0.029 DBMET03689 | DBMET03689 | |
| 0.002 | 0.996 | 0.07 | Farnesyltransferase inhibitor | 0.07 0.015 DBMET03688 | DBMET03688 | |
| 0.003 | 0.996 | 0.497 | Interleukin antagonist | 0.497 0.02 DBMET03690 | DBMET03690 | |
| 0.002 | 0.996 | 0.084 | Uric acid excretion stimulant | 0.084 0.076 DBMET03687 | DBMET03687 | |
| 0.002 | 0.996 | 0.131 | Glutamate receptor antagonist | 0.131 0.064 DBMET03687 | DBMET03687 | |
| 0.002 | 0.995 | 0.07 | Prostaglandin EP2 antagonist | 0.07 0.033 DBMET03689 | DBMET03689 | |
| 0.001 | 0.995 | 0.073 | Angiotensin AT2 receptor antagonist | 0.022 0.015 DBMET03687 0.073 0.006 DBMET03689 | DBMET03689 | |
| 0.003 | 0.997 | 0.582 | Antiinflammatory | 0.422 0.126 DBMET03687 0.582 0.059 DBMET03689 | DBMET03689 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |